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ABSTRACT 
 
Boundary elements consisting of barriers and insulators are genomic sequence elements that 
along with their associated DNA-binding proteins block the spread of heterochromatin into 
euchromatic regions or prevent the targeted activation of promoters from distal/proximal 
enhancers, respectively. In Saccharomyces cerevisiae, the deletion of RPD3, a histone 
deacetylase, results in an extended SIR protein-mediated silencing effect bypassing a tRNA
thr
 
barrier element adjacent to the cryptic mating locus, HMRa. We mutagenized rpd3∆ strains and 
identified suppressor mutants through a genetic screen that no longer displayed this enhanced 
silencing effect. Our results identified BRE1 and BRE2, which are either directly or indirectly 
responsible for the tri-methylation of histone H3K4 and H3K79, as effectors of the rpd3Δ 
extended silencing effect at HMRa. We hypothesize that the increased silencing effect in rpd3∆ 
mutants is the result of a redistribution of SIR proteins which become concentrated at the HMRa 
region in response to a global change in the acetylation and/or methylation state of histones 
contingent on RPD3, BRE1, and BRE2. ETC, or Extra-TFIIIC, sites are genomic elements which 
bind the RNA Polymerase III transcription factor, TFIIIC. ETC sites contain B-box promoter 
sequences normally associated with RNA Polymerase III promoters, and their locations are over-
represented between divergently transcribed RNA Polymerase II genes. Our results show that the 
transcription of TFC6, which codes for a DNA-binding component of TFIIIC, is auto-regulated 
by TFIIIC which binds to the ETC6 site in the TFC6 promoter region. Inhibition of TFIIIC binding 
to the ETC6 site results in increased TFC6 expression from its own promoter, and transcription 
of TFC6 is inversely correlated with TFIIIC binding to the ETC6 site. The TFC6 promoter is also 
down-regulated when its own gene product is over-expressed. We present here a novel function 
of gene regulation where a Pol III transcription factor directly (auto) regulates a Pol II gene. Our 
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results also point to how this regulation might be mediated by an insulator-like function of TFIIIC 
which can implicate the functionality of Extra-TFIIIC sites in other eukaryotes. 
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CHAPTER ONE 
INTRODUCTION 
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        Regulation of gene expression in eukaryotic cells involves a myriad of different genes 
turned on or off and expressed in different temporal arrays. This is the hallmark in the control of 
gene expression which dictates cellular responses to stimuli and cellular differentiation in 
eukaryotic organisms. Different activating or repressive transcription factors are employed at 
differing times to regulate the initiation or inhibition of transcription of different regions of 
chromosomes in isogenic cells. Any disruption in cellular processes that result in the 
misregulation of gene function and altered patterns of gene expression are key features of 
abnormal cell proliferation or cancerous cells. Studies are consistently revealing that acquired 
epigenetic abnormalities participate with genetic alterations to cause this misregulation. The 
silencing of genes by DNA methylation and the alteration of the underlying chromatin 
environment by histone modifications have led to the realization that genetics and epigenetics 
cooperate at all stages of cell development. A primary factor in optimal cellular function is the 
control of transcription, which is highly regulated so that genes are expressed only where and 
when needed in the cell. 
        The transcription of DNA in eukaryotic cells occurs via the multi-subunit RNA polymerase 
complexes which converts the DNA base sequence into an RNA strand with the same sequence 
of one of the DNA strands (with uracil replacing thymine). The eukaryotic core RNA 
polymerases have 12-20 different protein subunits and require many other accessory proteins for 
proper transcription. The transcriptional initiation of a gene generally begins with the recruitment 
of a preinitiation complex (PIC), which is positioned at or near the transcription start site of the 
gene. Proteins known as general transcription factors combined with the RNA polymerase 
complex constitute the PIC, the assembly of which is required to initiate transcription. The RNA 
polymerase separates the two strands of DNA and positions a ribose nucleoside tri-phosphate 
(rNTP) at the transcriptional start site. Once initiated, RNA polymerase can proceed to copy the 
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coding strand by polymerizing nucleotides 5’ to 3’ complementary to the template strand. RNA 
polymerases form a “clamp” structure to bind to DNA. Since many eukaryotic genes are very 
long, the polymerase must hold on tightly to have the high processivity required to make it to the 
end of the gene. Inside the RNA polymerase complex is a “transcription bubble” of about eight 
nucleotides where the newly synthesized RNA is base paired with the DNA template strand near 
the active site. This base pairing is critical to maintaining the integrity of the 
DNA:RNA:polymerase complex. Specific regulatory sequences within the DNA mark the start 
and the ends of the regions to be transcribed and determine which strand of DNA is used as the 
template for RNA synthesis. RNA polymerase does not require a primer to initiate synthesis, but 
is directed to the proper site on DNA by nearby cis-acting sequences called promoters. 
        Most genes have additional transcription factor binding sites at regions from less than a 
hundred to several thousands of base pairs from the promoter. These sequences are called 
enhancers, as they stimulate the frequency of transcription initiation from a promoter. Enhancers 
can be located upstream of genes, within introns, and even downstream of the gene. Enhancer 
function is typically orientation and distance independent unlike proximal promoters. Much of 
our direct knowledge of how enhancers might activate transcription comes from studies of yeast 
Upstream Activation Sequences (UAS), the yeast counterpart of metazoan enhancers (Farrell, 
Simkovich et al. 1996). Current evidence suggests that UAS-bound proteins interact with 
components of the transcription complex to increase the probability that the PIC will find (have a 
stable interaction with) the promoter. Current theories suggest that DNA is looped out to 
accommodate enhancer-promoter interactions. Another proposed mechanism for enhancer 
activity has included the targeting of chromatin-modifying enzymes to the promoter region, thus 
making the promoter more accessible to the transcription machinery.  
4 
 
        The regulation of transcription involves the utilization of transcriptional activators or 
repressors which can increase or decrease the rate of transcription of its target gene. 
Transcriptional activators such as Gal4, one of the first characterized transcription factors in 
yeast, have multiple domains that can fold and function independently. These proteins typically 
contain N-terminal DNA binding domains of various types along with a nuclear localization 
signal for import into the nucleus (Figure 1.1).  
 
         
 
 
Examples of DNA-binding domains include zinc modules, homeodomains, and bZIP or bHLH. 
There is also a domain for the dimerization of two independent monomers that are followed with 
activation domains which are rich in acidic amino acids near the C-terminal end. These 
activating regions can also consist of glutamine rich or proline rich domains. These transcription 
factors are brought in proximity to promoters where they function to activate or repress 
Figure 1.1. Generic transcription factor bound to sequence element. Transcriptional 
activators bind to sequence elements (e.g. promoters, enhancers or UAS in yeast) located either 
upstream or downstream of the +1 site. They are typically polypeptide monomers that dimerize 
and bind to sequence palindromes in the genome, but different transcription factors can also form 
heterodimers. These monomers typically contain an N-terminal DNA-binding domain (BD) that 
also contains a nuclear localization signal, a dimerization domain (hatched domain between AD 
and BD), and a C-terminal activation domain (AD) rich in acidic amino acids.  
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holoenzyme recruitment. Unlike prokaryotes which utilize a single RNA polymerase to 
transcribe their whole genome, eukaryotic cells contain three distinct RNA polymerases which 
partially overlap in subunit composition and are recruited by different general transcription factor 
complexes to transcribe different types of RNA molecules. RNA Polymerase I (Pol I), which is 
primarily located in the nucleolus, transcribes the larger RNA responsible for the main structural 
and catalytic center of the ribosome (rRNA) (Paule and White 2000).  
 
Weaver, R.F. Molecular Biology, 3
rd
 Ed. 2005. 
 
         
        The RNA Pol I promoter region consists of a “core” region bound by a complex of proteins 
called SL1 (Figure 1.2). This complex is essential to recruit Pol I to rRNA genes. The SL1 
complex contains TBP and three TAFIs (110, 63, and 48). The UPE or upstream promoter region 
is bound by a single polypeptide, named UBF (UPE-binding factor) in human cells, or UAF 
(upstream activation factor) in yeast. In vitro transcription of rDNA genes by Pol I requires both 
UBF and SL1 (Paule and White 2000). 
        RNA Polymerase II (Pol II), found throughout the nucleoplasm, transcribes the 
heterogeneous nuclear RNA (hnRNA). This hnRNA consists of mostly protein coding mRNAs, 
along with most small nuclear spliceosomal RNA. The Pol II complex contains 12 protein 
subunits, and the largest subunit (RPB1) has an unusual carboxy terminal domain (CTD) with 
nearly perfect repeats of the amino acids YSPTSPS (27 in yeast, 52 in human), and the functions 
of the CTD are highly regulated by phosphorylation on these residues. The IIA form of Pol II has 
Figure 1.2. Generic RNA polymerase I promoter. The RNA polymerase I gene promoter 
elements consists of the UPE or upstream promoter element in gold and the “core” region in blue 
containing the transcriptional start site or +1 site. 
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an unphosphorylated CTD and is the initiating form of the complex. The IIO form of Pol II is the 
elongating form, which is phosphorylated on its CTD. The CTD, which is essential for viability 
in yeast, also binds to components of chromatin remodeling complexes, and is involved in the 
splicing, termination, capping and polyadenylation of mRNAs. Besides RNA polymerase II, 
other factors are recruited to the promoter including the general transcription factors TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF, TFIIH, a mediator complex, and the TATA-binding protein (TBP) 
which is associated with TFIID. Generic Pol II promoters contain an initiator region around the 
+1 or CAP site, a TATA box, a TFIIB recognition element, and upstream and downstream 
promoter elements (Figure 1.3).  
 
Weaver, R.F. Molecular Biology, 3
rd
 Ed. 2005. 
 
 
 
 
The ordered assembly on Pol II genes is TFIID (which is also associated with numerous TAFIIs 
or TBP-associated factors), TFIIB, Pol II which requires the presence of TFIIH, then the other 
factors. TFIIB links TBP with the polymerase, TFIIA imparts directionality to the preinitiation 
complex; TFIIH functions as a helicase to unwind the strands of DNA allowing the 
polymerization of nucleotides complementary to the template strand and is stimulated by TFIIE 
Figure 1.3. Generic RNA polymerase II promoter. The upstream element in gold binds an 
activating transcription factor. BRE in purple is the TFIIB, a non-sequence specific general 
transcription factor, recognition element. The TATA box in red is an AT rich sequence about 25 
bases upstream of the CAP site and binds the TBP or TATA-binding protein. The initiator (Inr) 
in green is centered around the CAP site. The DPE or downstream promoter element is located 
downstream from the CAP site.  
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(Hahn 2004).TFIIF is hypothesized to direct the polymerase to preformed TFIID:TFIIA:TFIIB 
complexes. There are other Pol II promoter regions such as GC boxes which can bind the 
transcription factor SP1 and CCAAT boxes which binds CTF (CCAAT binding factor) or CEBP 
(CCAAT/Enhancer binding protein) (Hahn 2004).          
        RNA Polymerase III (Pol III) mainly transcribes the transfer RNA (tRNA) molecules that 
read the information encoded in the mRNA and translates it into protein sequence, but also 
transcribes the 5S ribosomal RNA, RNase P (RPR1), the U6 small nuclear spliceosomal RNA 
(SNR6), the cytoplasmic RNA of the signal recognition particle (SCR1), and Alu repeats (Paule 
and White 2000; Geiduschek and Kassavetis 2001; Huang and Maraia 2001). There are three 
types of RNA Polymerase III (Pol III) promoters which are grouped according to the 
organization of the binding sites for the core transcription factors TFIIIB and TFIIIC (Figure 1.4). 
Type 1 consists of the 5S ribosomal gene and contains an intragenic promoter region ICR (or 
Internal Control Region) which consists of a Box A and Box C sequence flanking an intergenic 
element (IE).                       
        Transcription of the 5S gene requires the additional gene-specific factor TFIIIA. In yeast, 5S 
RNA genes are arranged in tandem with the 35S RNA genes where there are arrays of 100-200 
copies of these genes. In contrast, the 274 tRNA genes with Type II promoters are distributed 
throughout the genome (Percudani, Pavesi et al. 1997; Hani and Feldmann 1998). The Type II 
promoter consists of intragenic A and B box elements, and includes all tRNA genes. The Type 
III promoter is a hybrid consisting of Box A and B elements and a TATA sequence in yeast. 
Human Type III promoters contain no Box A or Box B elements, but do contain TATA and 
downstream and upstream promoter elements.         
        The focus of this dissertation is principally on the Type II mechanism involved in tRNA 
transcription where both the presence of the Pol III complex and the transcription potential of the 
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tRNA gene can function as a chromatin boundary; and the Box B promoter sequence potentially 
functions as an insulator element. 
 
 Adapted from Schramm and Hernandez, (2002) 
       
 
 
 
 
        
In tRNA gene (Type II) transcription initiation, the Pol III specific transcription factor TFIIIC is 
recruited to the two intragenic sequences Box A and Box B downstream of the transcription start 
Figure 1.4. Different types of RNA polymerase III promoters. Type 1 promoter (5S) contains 
intragenic A and C boxes flanking an intergenic element (IE). All three elements of the Type I 
promoter are referred to as the Internal Control Region (ICR). Type 2 promoter (tRNA) contains 
an A and B box. Type 3 promoter (Hs U6) contains a Distal Sequence Element (DSE), a 
Proximal Sequence Element (PSE), and a TATA box all located upstream of the transcription 
start site (TSS) similar to RNA Polymerase II genes. The Saccharomyces U6 gene contains an 
intragenic A box, a TSS upstream TATA box, and a B box located surprisingly downstream of 
the transcription termination sequence (TTTT). Each promoter type above contains a plus 
number above the transcription termination sequence (TTTT) indicating the length of the gene in 
base pairs.  
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site and remains tethered to these highly conserved regions of DNA (Figure 1.5). Next, TFIIIC 
recruits the Pol III transcription factor TFIIIB that contains the TATA-binding protein (TBP) 
subunit, and is essential for transcription initiation.  
 
Robert Weaver, 4
th
 ed., (2008)        
 
         
 
 
TFIIIC thus indirectly influences start site selection (Bartholomew, Meares et al. 1990). Bound 
TFIIIB then recruits and correctly positions RNA Polymerase III at the transcription start site 
Figure 1.5. RNA polymerase III Type II (tRNA) transcription initiation. The transcription 
factor complex TFIIIC, through its DNA binding subunits, binds to Box A and Box B sequences 
within the coding region of the tRNA gene. TFIIIC recruits the transcription factor TFIIIB which 
contains TATA-binding protein (TBP) that participates in TFIIIB stability. TFIIIB then recruits 
RNA polymerase III where processive transcription can now occur. Reinitiation of transcription 
may or may not require the TFIIIC complex. 
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where transcription of the tRNA gene is initiated. TFIIIB-DNA complexes are competent to direct 
initiation and multiple rounds of transcription after TFIIIC complexes are stripped (Kassavetis, 
Braun et al. 1990). Mechanistically, TFIIIC bound at the Box A and Box B promoter elements 
opens the DNA duplex for the advancing Pol III (Bardeleben, Kassavetis et al. 1994). 
        Gene expression in eukaryotes is not simply regulated by the direct binding of repressors 
and activators to promoter elements along with the recruitment of a preinitiation complex, but 
also by the structure of the chromatin in which the given gene resides. Eukaryotic DNA is 
packaged and highly condensed in the nucleus through its association with histone proteins and 
additional non-histone chromatin associated proteins. Chromatin typically exists as two distinct 
states: euchromatin and heterochromatin (Figure 1.6).  
 
 
 
Euchromatin is the term that is associated with regions of the nucleoprotein complexes that are 
transcriptionally active, early replicating, and generally have hyperacetylated N-terminal histone 
Figure 1.6. Types of chromatin. Euchromatin (green nucleosomes), early replicating, 
transcriptionally active, hyperacetylated histone tails, less condensed structure; Heterochromatin 
(red nucleosomes), late replicating, transcriptionally repressed, hypoacetylated histone tails, 
more condensed structure with the binding of heterochromatin-associated proteins. 
Heterochromatin-associated proteins (e.g. Sir complex) are in yellow.  
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tails. Heterochromatin refers to a more condensed structure that is minimally transcribed, late 
replicating, and generally associated with hypoacetylated histone tails (Weiler and Wakimoto 
1995).  
        The maintenance of the silent and/or open state has been shown to be heritably stable for ten 
generations or more (Pillus and Rine 1989). These two states of chromatin are not necessarily 
static since the chromatin environment of the underlying DNA can change between the open and 
closed states depending on changes in histone modifications, the binding of chromatin-associated 
proteins, or the activity of different signaling proteins in the cell. Heterochromatic gene silencing 
differs from simple repression in that larger regions of chromosomes, not just individual 
promoters, are repressed. Not only is the transcriptional potential of any gene dependent on the 
underlying chromatin environment, but all aspects of eukaryotic DNA function (transcription, 
replication, recombination, repair) must occur within the context of chromatin where the 
nucleosome, a nucleoprotein complex, is the fundamental unit.  
        The nucleosome consists of an octamer of four core histone proteins H3, H4, H2A, and 
H2B (two of each) around which approximately 147 bp of DNA are wrapped, and also contains 
~20-60 bp of linker DNA which connects adjacent nucleosomes (~ 20 bp in S. cerevisiae, ~40-50 
in humans). These proteins are abundant and comprise ~50% of total nuclear protein. The core 
histones (H2A, H2B, H3, and H4) are small, positively charged (basic) proteins (20-25% lysine 
and arginine) that share a conserved domain which folds into a conserved structure, the histone 
fold domain. This protein structure is composed of three α-helices separated by two short loops. 
The structure mediates the formation of head to tail dimers of specific pairs of histones (H2A + 
H2B, H3 + H4), which mediates the assembly of the nucleosome core particle on DNA.  
        Nucleosomes are extremely stable protein-DNA complexes under physiological conditions 
because of 14 contact points that occur between the histone core and the DNA duplex, with >120 
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direct atomic interactions (Luger, Mader et al. 1997). The numerous contact points are well-
suited for the packing function that is required for chromatin, especially during mitosis. In higher 
eukaryotes, a histone H1 linker protein binds to linker DNA that adjoins two adjacent 
nucleosomes and participates heavily in chromatin remodeling through phosphorylation of H1 
during the condensation of chromosomes during mitosis (Allan, Cowling et al. 1981).  
        The histone proteins are mainly globular but have N-terminal tails that extend out from the 
nucleosome core and are also partly responsible for the compaction of chromatin, but are subject 
to different covalent modifications (e.g. acetylation, methylation, and phosphorylation) at 
specific residues. The specific pattern of histone modifications can determine whether 
transcriptional activators or RNA polymerase can bind to and/or function on the underlying 
DNA.  
        There are over 60 different residues on histones where modifications have been detected 
either by specific antibody binding or by mass spectrometry (Figure 1.7).  Extra complexity 
comes from the fact that methylation at lysines or arginines may be one of three forms: mono-, 
di-, or trimethyl for lysines and mono- or di- (asymmetric or symmetric) for arginines. These 
modifications have been shown to recruit other histone modification enzymes and/or chromatin 
remodeling factors (Luger, Mader et al. 1997; Lorch, Zhang et al. 1999; Wu and Grunstein 
2000). It has been shown that the N-terminal tails of histone H4 play a vital role in establishing a 
heterochromatin environment, since deletion of the N-terminal tails abolished the establishment 
of heterochromatin (Kayne, Kim et al. 1988). The covalent modifications that occur on the N-
terminal tails of histone proteins are hypothesized to represent a “histone code” indicating the 
expression state of the underlying chromatin (Strahl and Allis 2000; Turner 2000; Jenuwein and 
Allis 2001). Effector proteins translate this code by binding to specific modifications on the 
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histones. The binding of these effector proteins then can lead to further chromatin modifications 
which can ultimately dictate particular expression states of the underlying chromatin. 
 
 
 
          
         
         
Histone modifications are also known to reinforce or inhibit one another, with one modification 
affecting the likelihood of other modifications. The acetylation of lysine residues, the 
Figure 1.7. Summary of the most common post-translational histone modifications on the 
N-terminal histone tails and inside the nucleosome core. Depicted above is a schematic of the 
amino terminal tails of histones H3, H4, H2A, and H2B (only one each shown for clarity) 
extending out from the nucleosomal core. The N-terminal tails are subjected to different post-
translational modifications depending on the specific amino acid residue and position. Shown 
above are the amino acids, K (Lysine), R (Arginine), S (Serine) with their numbered position 
along with the modification. Me is methylation (Red), Ac is acetylation (Light Blue), P is 
phosphorylation (Purple), and Ub is Ubiquitylation (Gold). 
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methylation of lysine and arginine residues, the phosphorylation of serine residues, and 
ubiquitylation of lysine residues on histone proteins have all been implicated in the activation of 
transcription; whereas certain residues of histone proteins with modifications of methylation, 
ubiquitylation, sumoylation, deamination, and proline isomerization have been implicated in 
transcriptional repression.  
        Histone proteins H3 and H4 that have acetylated lysine residues typically have roles in 
transcriptional activation and sometimes even in repression (Fisher-Adams and Grunstein 1995; 
Megee, Morgan et al. 1995); whereas the N-terminal tails of H3 and H4 are hypoacetylated in 
silenced heterochromatin (Braunstein, Rose et al. 1993; Suka, Suka et al. 2001). The acetylation 
state of the histone tails is believed to determine DNA-histone compaction by virtue of the 
interacting charges between the modified amino acid and the DNA backbone. The DNA 
backbone is negatively charged and wrapped around a positively charged histone core. The 
acetylation of lysine residues seems to partially relieve DNA-histone compaction by neutralizing 
the lysine residue’s positive charge.  
        Three distinct classes of histone deacetylases (HDAC) have been discovered: class I, II, and 
the class III NAD
+
-dependent enzymes of the SIR (Silent Information Regulator) family. The 
histone deacetylase, Sir2p, preferentially deacetylates H4K16 in vitro and is essential in 
establishing in vivo silencing in S. cerevisiae (Imai, Armstrong et al. 2000; Meijsing and 
Ehrenhofer-Murray 2001; Tanny and Moazed 2001; Suka, Luo et al. 2002). In general, HDACs 
do not have preference for a particular acetyl group but some, like Sir2p, do have specificity for 
a particular histone such as Hda1p for H3 and H2B, and Hos2p for H3 and H4 (Vaquero, Scher 
et al. 2006).  
       Lysine methyltransferases have enormous specificity compared to acetyltransferases as they 
usually modify only one lysine residue on a single histone and can either be activating or 
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repressive to transcription (Bannister and Kouzarides 2005). The methylation of lysine 4 on H3 
appears to be a euchromatic imprint in a wide range of organisms (Strahl, Ohba et al. 1999). In 
other higher eukaryotes, including Schizosaccharomyces pombe (S. pombe), methylation of 
lysine 9 on H3 (H3K9) and lysine 27 on H3 (H3K27) are characteristic methylation marks in 
heterochromatic regions. These heterochromatic regions include the presence of the 
chromodomain-containing Heterochromatin Protein 1 (HP1) and a significant lack of acetylation 
marks. HP1 mediates the recruitment of additional chromodomain-containing Histone Methyl 
Transferase (HMT) activity to establish heterochromatic states in higher eukaryotes. There are 
only three known histone H3 methylation sites in yeast – H3K4, H3K36, and H3K79 and each 
has a specific distribution pattern. Dot1p is a lysine methyltransferase in yeast specific for 
H3K79 which is unexpectedly located in the nucleosome core (Feng, Wang et al. 2002; van 
Leeuwen, Gafken et al. 2002). The methylation of lysine 79 of histone H3 is thought to prevent 
the binding of Sir proteins (van Leeuwen, Gafken et al. 2002). The methylation of histone H3 
lysine 4 (H3K4) in S. cerevisiae is mediated by Set1p (Briggs, Bryk et al. 2001).  
        The influence of the histone code is expanding in relation to the methylation state of both 
lysine and arginine residues. Since methylation of lysine residues can also occur as a mono-, di- 
or tri-methylation on a single lysine residue, new evidence is beginning to show a differential but 
gradual distribution of di- and tri-methylation patterns between promoter regions and open 
reading frames (Cuthbert, Daujat et al. 2004; Carrozza, Li et al. 2005; Joshi and Struhl 2005; 
Keogh, Kurdistani et al. 2005). This significantly adds to the complexity of the underlying 
histone code in determining open or closed chromatin states. Currently, there is only one known 
H3K4me3 demethylase in budding yeast, JhD2p (Liang, Klose et al. 2007). Due to limiting 
histone lysine demethylases, the methylation of lysine residues seems to represent a more long-
term epigenetic mark for maintaining chromatin states, as DNA replication and semiconservative 
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nucleosome distribution appears to be the sole means to “dilute” histone lysine methylation 
below a critical threshold level.  
        The phosphorylation of serine residues by specific kinases on N-terminal histone tails is 
most prominent during cell division. This modification is spatially and temporally correlated 
with mitotic and meiotic chromatin condensation (Wei, Mizzen et al. 1998). Many protein 
phosphorylation cascades may have a more direct effect on gene expression through the 
phosphorylation of chromatin at serine residues. Snf1p, a kinase in budding yeast has been 
shown to target H3S10. 
        The relatively large modification of ubiquitylation on lysine residues can be found mainly 
on the histone proteins H2A and H2B. The modification of H2BK123 in yeast is mediated by 
Rad6/Bre1, an E2 ubiquitin-conjugating/E3 ubiquitin-ligase, and is required for the subsequent 
trimethylation of H3K4 and H3K79 which is associated with transcriptional activation (Zhu, 
Zheng et al. 2005). The chromatin-modifying functions of ubiquitylation are somewhat unclear. 
It more than likely recruits additional chromatin factors, but may also function to physically keep 
chromatin open by a “wedging” process, given its large size. 
        The genomes of multi-cellular organisms consist of different hypothetically demarcated 
regions of gene expression based on whether or not the underlying DNA is in an open or closed 
conformation. The demarcation line between these differing regions of expression can occur on 
sequence elements between regions of differing chromatin states, resulting in position effect 
silencing of adjacent genes and/or blocked transcriptional activation of nearby gene promoters. 
These sequence elements along with their associated DNA-binding proteins are known as 
boundary elements and are functionally characterized as either barriers that block the spread of 
heterochromatic silencing into regions of open and transcriptionally active genes, or as insulators 
that block the transcriptional activation of genes by enhancers from distal (or even proximal) 
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genomic regions (Figure 1.8). Enhancer blocking only occurs if the insulator is situated between 
the enhancer and promoter, not if it is placed elsewhere.  
 
 
 
         
Most studies on enhancer-blocking deal primarily with protein-protein interactions that may 
interfere with the activity of complexes mediating normal enhancer-promoter communication. 
Compound elements are sequence elements that contain closely-spaced enhancers and enhancer-
blockers that are typically polar in nature (West, Gaszner et al. 2002). Some blocking elements 
(insulators) do appear to show polarity function in an orientation-dependent manner, unlike 
enhancers which are typically both orientation- and distance-independent (Hark, Schoenherr et 
al. 2000; Bell, West et al. 2001). A wide variety of enhancer-blocking elements have been 
identified (mainly in Drosophila) and an increasing number are being found in vertebrates 
(Kellum and Schedl 1991).  
Figure 1.8. Two types of boundary elements: barriers and insulators. Barriers are sequences 
within the genome and their associated DNA-binding proteins (green oval) that block the spread 
of heterochromatin (yellow/red) into euchromatic regions (green/orange). Insulators are 
sequence elements along with their DNA-binding proteins that block the promiscuous 
transcriptional activation of gene promoters from distal and proximal enhancers. 
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        Saccharomyces cerevisiae, commonly known as budding yeast, is unicellular, but grows as 
individual isogenic cell colonies descended from one original cell on plated media; and was the 
first eukaryotic organism to have its genome sequenced, thus making all genes and their 
sequences available for study in all aspects of gene regulation, including chromatin boundary 
elements. The yeast genome is relatively easy to manipulate, which makes it a very desirable 
model for analyzing the mechanisms involved in chromatin remodeling and gene regulation. 
Also, study of the yeast model is very desirable because many of the proteins in yeast are 
conserved through evolution and are homologous to proteins in higher eukaryotic organisms, 
which can provide insight into the function of genes across species. The established model for 
the study of boundary elements (barriers) in Saccharomyces is best exemplified by a tRNA gene 
(tDNA) on chromosome III immediately downstream of the cryptic mating-type loci, HMRa.  
        In Saccharomyces cerevisiae, heterochromatic silencing occurs at the cryptic-mating loci 
HMRa (Homothallic Right) and HMLα (Homothallic Left), ribosomal DNA, and telomeres. In 
most strains, HMLα contains a cryptic copy of the MATα genes and HMRa contains a cryptic 
copy of the MATa genes (Figure 1.9). Homothallic strains of S. cerevisiae have the ability to 
interconvert their mating types either from a to α, or from α to a, as frequently as once every 
other generation. The ability of S. cerevisiae to switch haploid mating types depends on the HO 
gene. The HO gene encodes a sequence-specific endonuclease that cleaves the mating type locus 
to create a double strand break in the DNA. The repair of the cleavage occurs by a mechanism 
similar to gene conversion using homologous recombination machinery, in which a silent copy 
of the mating-type genes at either HMR or HML is copied into the transcriptionally active 
euchromatic MAT locus (Haber 1998). Most laboratory strains do not contain an active copy of 
the HO gene, so a stable haploid state can be maintained for study using various genotype 
combinations after meiotic recombination and sporulation.  
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Within the yeast nucleus, HMRa (or HMR) exists as 12 ordered nucleosomes arranged in six 
pairs of closely spaced nucleosomes separated from one another by longer linkers and spans 
~3.5kb of DNA (Mastrangelo, Weinstock et al. 1992; Ravindra, Weiss et al. 1999).  
        The sequence elements flanking both HM loci are silencing initiators termed E and I 
silencers (Essential and Important). The E and I silencer elements contain ARS (Autonomously 
Replicating Sequences) which are binding sites for the Origin Recognition Complex (ORC). The 
E silencer is primarily responsible for the initiation of silencing with the binding of Abf1p 
(Autonomously replicating sequence Binding Factor), Rap1p (Repressor Activator Protein), and 
ORC; whereas the I silencer only binds Abf1p and ORC (Moazed 2001; Huang 2002). ORC and 
Rap1p are only required for the initiation of silencing and not any other subsequent silencing 
event. At HMR, silencing is most robust between the two silencer sequences, E and I, where the 
haploid-specific cryptic mating type genes (a1a2) are positioned (Rusche, Kirchmaier et al. 
2003).  
Figure 1.9. Schematic representation of the HMLα, MAT, and HMRa loci in S. cerevisiae. 
The MAT locus is transcribed and determines cell type, a or α by expression of a1a2 or α1α2, 
respectively. The cryptic HMRa and HMLα loci are located near each end of chromosome III. 
Both HM loci are flanked by the E and I silencers that bind ORC1p, Rap1p, and Abf1p for the 
initiation of silencing. This nucleation of sequence-dependent binding proteins is succeeded by 
the binding of the silencer (Sir) proteins which propagates the silencing effect and thus the 
establishment of heterochromatin. 
Yeast Chromosome III 
MAT locus – Transcribed 
HM loci – Transcriptionally silenced, but identical 
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        In S. cerevisiae, silenced domains consist of continuous distributions of SIR proteins along 
the chromosome that are targeted by hypoacetylated nucleosomes, and are thought to form an 
ordered, compact structure that restricts transcription (Hecht, Strahl-Bolsinger et al. 1996; Strahl-
Bolsinger, Hecht et al. 1997; Lieb, Liu et al. 2001; Rusche, Kirchmaier et al. 2002). 
Interestingly, the inheritance of silenced chromatin domains has been shown to be remarkably 
stable during both mitosis and meiosis (Grewal and Klar 1996) and the tails of histones H3 and 
H4 are unacetylated at most positions (Braunstein, Rose et al. 1993; Braunstein, Sobel et al. 
1996; Suka, Suka et al. 2001). 
         The propagation of silent heterochromatin through HMR is sequence-independent and 
mediated by the Sir proteins after the initiation of silencing at the E and I silencers. The Sir 
complex, which contains Sir2p, Sir3p, and Sir4p, is recruited to the silencers through the 
initiating DNA-binding proteins of ORC1p, Rap1p, and Abf1p (Figure 1.10). Sir1p binds to 
ORC1p and sets the stage for the binding of the other Sir proteins. Sir4p binds next and is known 
to interact with both Sir1p and Rap1p. The binding of Sir4p to the silencer does not require Sir2p 
or Sir3p but instead is responsible for the initial recruitment of Sir2p. Sir4p is required for the 
binding of Sir3p which also possibly binds to Abf1p. Sir2p not only functions in the structural 
integrity of silencing at heterochromatic regions of yeast, but is also a histone deacetylase which 
is dependent on Nicotinamide Adenine Dinucleotide (NAD
+
) as a cofactor (Rusche, Kirchmaier 
et al. 2003).       
        In the propagation of heterochromatin (silencing), the enzymatic deacetylation by Sir2p of 
the adjacent nucleosome coupled with the hydrolysis of NAD
+
 creates sites on histones where 
Sir3p and Sir4p can bind with higher affinity to the N-terminal histone tails of the adjacent 
nucleosomes. The Sir complex then proceeds to propagate along an array of deacetylated 
nucleosomes.  
21 
 
 
 
         
 
         
         
        Downstream of the I silencer sequence at the HMR locus is a boundary element of the 
barrier type which consists of a tRNA
thr
 gene. Deletion of this tDNA (tRNA gene) can lead to a 
significant loss of boundary element function. Also, mutations that affect the activity of the RNA 
Polymerase III transcription factors TFIIIC or TFIIIB impairs the barrier function of this tDNA. 
Disruption of the barrier can occur from tDNA mutations in the tRNA
thr
 promoter, which 
Adapted from Rusche, Kirchmaier, and Rine, Mol. Biol. Cell, v13, p2207, 2003 
Figure 1.10. Initiation and propagation of heterochromatic silencing at the E silencer 
through the HMR locus in S. cerevisiae. A) Initial recruitment of DNA-binding proteins Orc1p, 
Rap1p, and Abf1p along with the Sir proteins in an ordered assembly. B) Sir2p deacetylates the 
adjacent nucleosome creating a high affinity binding site for Sir3p and Sir4p. C) Propagation of 
silent heterochromatin begins with the deacetylation action of Sir2p and the ordered assembly of 
Sir proteins. D) A repetition of this process leads to silencing of the entire region. 
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eliminates a nucleosome-free gap by inhibiting the binding of the entire Pol III complex, or by 
mutations in either the GCN5 or SAS2 genes that encode histone acetyltransferases, which affect 
global chromatin processes (Donze, Adams et al. 1999). Another gene that could play a role in 
the integrity of the barrier element by affecting global processes is the histone deacetylase RPD3 
(Jambunathan, Martinez et al. 2005).  
        RPD3 or Reduced Potassium Dependency encodes the catalytic subunit of two functionally 
different histone deacetylase complexes, is conserved between humans and yeast, and can either 
repress or lead to activation of transcription when targeted to promoters. Two Rpd3 complexes 
have been characterized and have been designated as Rpd3 small and large complexes, Rpd3(S) 
and Rpd3(L). Rpd3(S) functions within coding regions of genes to prevent erroneous 
transcription initiation by recognizing Set2p methylated histones (H3K36) through its Eaf3p 
chromodomain where it deacetylates histones within these transcribed sequences (Carrozza, Li et 
al. 2005). Rpd3(L) functions specifically at repressed promoters through contacts with DNA 
binding repressor proteins (Keogh, Kurdistani et al. 2005).  
        Curiously, while the deletion of RPD3 leads to higher global acetylation levels, at the same 
time, silencing is enhanced at the cryptic mating loci (specifically HMR) and telomeres (Vannier, 
Balderes et al. 1996), even overriding the tDNA barrier element adjacent to the HMR locus 
(Jambunathan, Martinez et al. 2005). In rpd3∆ mutants, it was found that a fraction of Sir2p 
molecules was delocalized from the nucleolus (rDNA) and became enriched at the regions of 
DNA adjacent to telomeres and at the silent HM loci (Santos-Rosa, Bannister et al. 2004; 
Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009). Through our own 
experimentation with an ADE2 marker gene inserted downstream of the tDNA boundary 
element, strains deleted for RPD3 showed that silencing bypasses the tDNA barrier element and 
represses the inserted ADE2 marker gene (Figure 1.11). 
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The laboratory created ADE2 inserted strains harbor an intrinsic mutation in its genomic ADE2 
gene, making the parent strains auxotrophic for adenine. The silencing of this ectopic ADE2 gene 
results in the build-up of intermediates in the adenine biosynthesis pathway which are converted 
to a red pigment and reflected as a colony color phenotype.  
        The silencing paradox that exists in rpd3Δ strains is evident by the fact that Rpd3p is a 
histone deacetylase, the action of which is associated with heterochromatin. Intuitively, the 
deletion of RPD3 should result in the increase of global histone acetylation levels and thus a 
decrease or an abolishment of silencing. What is the mechanism of this rpd3Δ silencing effect? 
What role would Rpd3p play in halting the enhanced spreading of silencing heterochromatin? 
Are there any other extraneous effectors mediating this silencing effect? Does Rpd3p play a 
Figure 1.11. Deletion of RPD3 affects the spreading of silencing heterochromatin at HMRa. 
Both wild-type (WT) and rpd3Δ representations of the HMR region are depicted above with E 
and I silencers in blue, the mating type specific genes (a1a2) in green, the barrier tRNA
thr
 in 
brown, and the inserted ADE2 gene either active (white) or silenced (red). The spreading of 
silencing (represented by the red arrow) begins at the silencers and is halted at the barrier in WT 
cells where the ADE2 gene is active and produces a white colony color phenotype in S. 
cerevisiae cells. Silencing in rpd3Δ cells bypass the barrier element and the spreading of 
silencing heterochromatin proceeds through to repress transcription of the ADE2 gene, thus 
resulting in a red colony color phenotype. 
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major role in boundary integrity? Rpd3 has many roles in maintaining genome integrity and one 
focus of this dissertation was to study the mechanisms which lead to the enhanced silencing 
effect in rpd3Δ strains of S. cerevisiae, which bypass the barrier element of tRNAthr at the HMR 
loci. 
        Emerging studies are revealing that tDNAs not only function as transcription units for 
transfer RNA molecules essential for translation and barrier elements to heterochromatic 
propagation, but also perform numerous other extra-transcriptional roles which can potentially 
have effects on chromatin state and genomic organization. Chromatin bound Pol III complexes 
mediate the targeting of Ty element integration (Chalker and Sandmeyer 1992; Kirchner, 
Connolly et al. 1995; Devine and Boeke 1996), the blocking of replication fork progression 
(Deshpande and Newlon 1996), condensin and cohesin recruitment (Dubey and Gartenberg 
2007; Haeusler, Pratt-Hyatt et al. 2008), and inhibition of transcription from nearby Pol II 
promoters (Kinsey and Sandmeyer 1991; Hull, Erickson et al. 1994; Bolton and Boeke 2003; 
Simms, Miller et al. 2004) (Figure 1.12).  
        Yeast TFIIIC is a large, multi-component protein of 570 kDa consisting of six polypeptides 
of 138, 131, 95, 91, 60 and 55 kDa which correspond to the genes TFC3, TFC4, TFC1, TFC6, 
TFC8, and TFC7 respectively. No single component of TFIIIC seems to be able to bind DNA on 
its own; instead, TFIIIC tends to bind as a complete complex. Studies in both budding and fission 
yeast initially identified the presence of chromosomal sequences that are bound by the TFIIIC 
complex, but not the other Pol III transcription factors TFIIIA, TFIIIB, or the Pol III enzymatic 
complex itself (Harismendy, Gendrel et al. 2003; Roberts, Stewart et al. 2003; Moqtaderi and 
Struhl 2004; Noma, Cam et al. 2006), and similar sites have recently been identified in human 
cells (Canella, Praz et al. 2010; Moqtaderi, Wang et al. 2010; Oler, Alla et al. 2010; Raha, Wang 
et al. 2010). 
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These sequences are referred to either ETC (Extra-TFIIIC) or TFIIIC-only sites in budding yeast 
and humans, and COCs (Chromatin Organizing Clamps) in fission yeast (Roberts, Stewart et al. 
Figure 1.12. Extra-transcriptional effects of tDNAs. tDNAs cause a nucleosomal shift (A) 3’ 
to 5’overriding sequence specificity for the nucleosome (red), direct the 5’ integration of Ty 
retrotransposons (B), block the progression of replication forks (C), repress Pol II genes by 
proximity (D), and block the spread of silencing heterochromatin into euchromatic regions (E).   
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2003; Moqtaderi and Struhl 2004; Noma, Cam et al. 2006) and contain only the intragenic Box B 
sequences of the Type II RNA Polymerase III genes (tRNAs) (Figure 1.13).  
 
 
     
         
Interestingly, the conserved regions of ETC sites in Saccharomyces are over-represented at 
divergently transcribed Pol II genes. Some of these ETC (or COCs) sites in budding and fission 
yeast have been shown to function as chromatin boundary elements (Noma, Cam et al. 2006; 
Simms, Dugas et al. 2008), however, the genome-wide function of most of these TFIIIC-bound 
sites remains unknown. The B box sequences are highly conserved among tRNA genes (Dieci, 
Percudani et al. 2000) and the interaction of TFIIIC with the B block sequence functions to some 
extent in a distance- and orientation-independent manner (Burnol, Margottin et al. 1993).  
        ETC or TFIIIC-only loci were first identified in genome-wide distribution assays of RNA 
Pol III transcription components using ChIP followed by microarray hybridization (ChIP-CHIP) 
in S. cerevisiae. Eight loci were identified as having only TFIIIC occupancy and were not 
occupied by any other Pol III factor and were found to be highly conserved among the four yeast 
Figure 1.13. The ETC (extra-TFIIIC) site. ETC sites are conserved RNA Pol III type II 
intragenic Box B sequences which are dispersed throughout the genome. The Pol III 
transcription factor TFIIIC stably binds to these ETC sites which are overrepresented between 
divergently transcribed RNA Pol II genes. 
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species: S. cerevisiae, S. mikatae, S. bayanus, and S. paradoxus (Moqtaderi and Struhl 2004) 
(Figure 1.14). 
 
Modified from Moqtaderi and Struhl, Mol. Cell Bio., v24, 2004, p4123         
 
 
 
These sites were found to contain an eleven nucleotide consensus in S. cerevisiae, and there is 
also a 100% sequence conservation of three additional nucleotides located 6 to 8 bases 
downstream of the B block consensus. The final C in this sequence is significantly conserved 
upon alignment of the B block of the 274 tRNA genes. Perfect conservation of the three 
additional nucleotides is found at all ETC loci but in only 21 out of 274 tRNAs. The ZOD1 locus 
Figure 1.14. Extra-TFIIIC (ETC) sites discovered in different Saccharomyces species. B 
block alignment of ETC1 to ETC8 including the ZOD1 locus. The B block consensus is derived 
from 274 tRNAs. The ETC consensus is derived from four different Saccharomyces species. The 
height of each letter is directly proportional to its degree of identity across contributing species. 
Adjacent Pol II genes are indicated in parentheses with a hyphen.  
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differs from the other ETC sites in that it is bound by all Pol III components (Moqtaderi and 
Struhl 2004).  
        Microscopic examination of S. pombe nuclei showed that distant COC sites localize to form 
a limited number of clusters at the nuclear periphery (Noma, Cam et al. 2006). COC loci in S. 
pombe are also often positioned near CCCTC-binding factor (CTCF) binding sites suggesting a 
possible role in chromatin insulation. A number of ETC loci also have binding motifs for the 
ETS transcription factor, but the connection between ETS and TFIIIC remains unknown (Noma 
and Kamakaka 2010). Under strict experimental criteria, 1,865 ETC sites were identified in 
humans with the implication of several thousand more. In humans, the distribution of TFIIIC-
occupied loci of both ETC and non-ETC types revealed a positional bias toward the 
transcriptional start sites (TSSs) of Pol II genes, as 181 ETC loci with the highest levels of TFIIIC 
showed occupancy near the TSSs of Pol II genes, with 68% being located within 1kb of a Pol II 
TSS (Moqtaderi, Wang et al. 2010). Also, the strongest TFIIIC-bound loci were within 200bp of 
CCCTC-binding factor (CTCF) sites (Noma and Kamakaka 2010).  
        The purpose of this study is to further our understanding of gene regulation mediated by 
boundary elements in S. cerevisiae and the mechanisms behind these particular functions. 
Previous studies at HMR have shown that although the spread of heterochromatic silencing in 
RPD3 mutants is not halted at the tDNA barrier, it does not appear to affect transcription of the 
tRNA gene (Donze, Adams et al. 1999; Donze and Kamakaka 2001), so RPD3 must play a role 
in restricting the spread of silencing at HMR. This different mechanism may involve global 
changes in histone modifications which in turn can affect the recruitment of specific chromatin-
associated proteins at that region. Studies of ETC sites in yeast have suggested that they may 
function as chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008); 
and mapping of the ETC6 site to the TFC6 promoter suggested that the TFIIIC complex might be 
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involved in auto-regulation of the TFC6 gene (Moqtaderi and Struhl 2004) and can potentially 
function as an insulator to the targeted activation of the TFC6 promoter (Figure 1.15).  
  
 
 
 
 
At the TFC6 locus, our previous studies have shown that deletion of the ETC6 (B box) site 
results in increased relative TFC6 gene expression, whereas deletion of ETC6 plus all sequences 
upstream of ETC6 through to the transcription start site of ESC2 (the divergently transcribed Pol 
II gene at the ETC6 locus) resulted in a surprising decrease of TFC6 transcription (Simms, Dugas 
et al. 2008). These results suggested that the ETC6 site directly functions in the regulation of 
TFC6, and that it may be due to an insulator-like activity. 
        In overview of this dissertation, the second chapter examines factors affecting barrier 
elements by elucidating the mechanisms or effectors of the enhanced rpd3Δ silencing effect that 
Figure 1.15. Model of autoregulation at the TFC6 locus. Schematic of the TFC6 locus 
including the promoter region that contains ETC6. The divergently transcribed Pol II genes, TFC6 
and ESC2, are in blue and the ETC6 site is in orange. TFC6 encodes the Tfc6p subunit (green) of 
the TFIIIC transcription complex (green) that either binds to ETC6 or other RNA Pol III binding 
sites. The binding of TFIIIC to ETC6 potentially functions as an insulator to the activation of 
TFC6 expression by a potential UAS (blue triangles) and an unidentified UAS-bound transcription 
factor. 
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bypasses the natural tRNA
thr 
barrier at the HMR region. Using a genetic screen, we proposed to 
identify potential mechanistic effectors of the rpd3Δ silencing effect and subsequently analyze 
these effectors. Using UV-mutated strains of rpd3Δ cells, we identified and analyzed seven 
different genes which when individually deleted, revealed that only two of the seven genes 
reversed the increased silencing effect in rpd3Δ strains. 
        The third chapter examines a novel autoregulatory mechanism with potential insulator 
activity of TFIIIC bound at ETC6 in the TFC6 promoter. Since TFIIIC binds to the B box 
sequence of ETC6, we propose that TFIIIC may have a direct effect on the regulation of the TFC6 
gene through either an insulator-like mechanism, or by competing for binding with an 
uncharacterized transcription factor that binds immediately upstream. We also propose that this 
novel function is the first known example of an RNA Polymerase III core transcription factor 
(TFIIIC) directly regulating an RNA Polymerase II promoter (TFC6). Finally, chapter four will 
include a more thorough discussion of the results of both studies and the implications of those 
results. This section will also include new strategies for future experiments and/or directions for 
these studies of barriers and insulators as boundary elements in light of new evidence. 
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INTRODUCTION 
        DNA in eukaryotic cells exists in the context of chromatin where the nucleosome is the 
fundamental unit. The nucleosome consists of 147 bp of DNA wrapped 1.7 times around histone 
proteins H3, H4, H2A, and H2B (2 subunits each) with N-terminal tails on each individual 
histone polypeptide extending out from the nucleosome core. These N-terminal tails are partly 
responsible for the compaction of chromatin and are subject to different covalent modifications 
(e.g. acetylation, methylation, and phosphorylation) at specific residues. These modifications 
have been shown to recruit other histone modification enzymes and/or chromatin remodeling 
factors (Luger, Mader et al. 1997). A combinatorial code may exist for the distribution of both 
type and location of histone modifications which can serve as molecular docking sites for the 
recruitment of specific regulatory proteins and/or transcriptional machineries. 
        Chromatin environments display mainly two major states of architecture, euchromatin and 
heterochromatin. Euchromatin is a more open state where the underlying DNA is accessible to 
the transcription machinery, and heterochromatin is a more closed, condensed state of compact 
nucleoproteins and additional protein complexes making the underlying DNA inaccessible to 
transcription. Regulation of regions that in either open or closed states is crucial for proper gene 
expression during differentiation of cell types and for overall proper genomic functioning within 
living cells. Numerous protein complexes interact not only with DNA but also associated 
chromatin proteins to modify particular histone proteins, to recruit ATP-dependent chromatin 
modifying enzymes, and to silence certain regions of the genome (Luger, Mader et al. 1997; 
Lorch, Zhang et al. 1999; Wu and Grunstein 2000). 
        Saccharomyces cerevisiae contains regions in its genome where the spreading of 
heterochromatic silencing is essential for proper functioning of the cell. These regions include 
the cryptic mating-type loci, HMRa and HMLα, the telomeric ends of chromosomes, and 
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ribosomal RNA (rRNA) genes (Rusche, Kirchmaier et al. 2003). In this study, we preferentially 
examined the cryptic mating locus region of HMRa, which is an ideal model for the initiation, 
propagation, and establishment of heterochromatic silencing of particular mating type genes. 
This silencing is initiated by the silencer sequence regions E and I that bind sequence-dependent 
proteins generally involved in DNA replication and transcription activation (e.g. ORC, Rap1p, 
Abf1p). Silencing is then propagated downstream of the silencer sequences, and at the mating 
loci is essential in maintaining a particular yeast haploid cell mating type, a or α. 
        The propagation of silent heterochromatin at HMR is sequence-independent and mediated 
by the binding of Silent Information Regulator (SIR) proteins. Sir2p is an NAD
+
-dependent 
histone deacetylase that is required for silencing of heterochromatic regions in yeast. The 
propagation of silencing proceeds downstream through the HMR by the deacetylation action of 
Sir2p on the successive nucleosomes coupled with the hydrolysis of NAD
+
 and the subsequent 
binding of the other Sir proteins (Sir3p, Sir4p, etc.) (Rusche, Kirchmaier et al. 2003). 
        Rpd3p, another histone deacetylase, is the enzymatic subunit of two characterized 
complexes, Rpd3(L) and Rpd3(S). Rpd3(L) represses transcription when targeted by promoter-
specific transcription factors, and Rpd3(S) prevents erroneous transcription initiation within 
coding regions by recognizing Set2p methylated histones (at H3K36), where it then deacetylates 
those histones within transcribed sequences (Carrozza, Li et al. 2005; Keogh, Kurdistani et al. 
2005). In yeast, RPD3 deletion surprisingly enhances silencing at the cryptic mating loci and 
telomeres (Vannier, Balderes et al. 1996) even overriding the tDNA barrier element adjacent to 
the HMRa locus (Donze and Kamakaka 2001; Jambunathan, Martinez et al. 2005). 
        We hypothesized that the increased silencing in rpd3∆ mutants may be due to the de-
repression of genes that increase silencing. This gave us the rationale to first perform a genetic 
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screen to identify potential effectors of the rpd3Δ silencing effect. To understand the mechanism 
of enhanced silencing in yeast lacking RPD3 by identifying potential effectors of this silencing 
effect, we used ultraviolet light to mutagenize rpd3∆ strains, which contained an inserted ADE2 
marker gene downstream of the HMR locus. We identified suppressor mutants that no longer 
displayed an enhanced silencing phenotype. These genes were subject to individual gene 
replacements with the LEU2 marker gene (knockouts) and crossed back to an rpd3Δ background 
and assessed for a change in colony color phenotype.  
        At HMR in wild-type strains, the tRNA
thr 
gene functions as a barrier element that blocks the 
spread of silencing into an ectopic ADE2 marker gene. In rpd3∆ strains, silencing spreads past 
the barrier element and into the downstream ADE2 gene, thus silencing the expression of this 
gene. Silencing of the ADE2 gene results in accumulation and polymerization of P-
ribosylaminoimidazole (AIR) molecules in the adenine biosynthesis pathway which results in a 
red/pink pigment reflected in yeast colony color. Since Sir-dependent mediated silencing also 
occurs at telomeres, we also took advantage of an inserted telomeric URA3 gene on chromosome 
VII-L to assess Sir-mediated silencing at telomeres in our genetic screen and test for mechanistic 
consistencies between the HMR and the telomere.  
        From this genetic screen, we identified seven genes which when disrupted reversed the 
extended heterochromatin formation at HMR in rpd3∆ backgrounds: BRE1, GDH2, BRE2, 
GAT3, QNS1, NPT1 and RXT3. It has been previously shown that NAD
+
 biosynthesis pathway 
genes (NPT1 and PNC1) are either directly or indirectly involved in the regulation of Sir2p 
activity and silencing at rDNA and telomeres (Sandmeier, Celic et al. 2002), therefore we asked 
if expression levels of those genes were altered by deletion of RPD3. Using Northern analysis to 
assess the expression of these NAD
+
 biosynthesis pathway genes, our studies showed no 
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difference in the expression levels of the genes NPT1, QNS1, or PNC1, between our WT and 
rpd3∆ strains. These genes were not studied further as potential effectors. There was also the 
potential that Rpd3p, which complexes with Ume6p to repress promoter regions, could act as a 
repressive transcription factor for GDH2 expression. The product of GDH2 is an NAD
+
-
dependent glutamine dehydrogenase, so the requirements of Gdh2p could potentially be affected 
by the availability of Sir2p and its enzymatic requirements of NAD
+
 (Kurdistani, Robyr et al. 
2002). Also, the only yeast H3K4 trimethyl demethylase, Jhd2p, contains a JmjC domain which 
has been shown to directly remove lysine methylation via a hydroxylation reaction that requires 
iron and α-ketoglutarate as cofactors (Klose, Kallin et al. 2006; Tsukada, Fang et al. 2006). 
Because glutamate dehydrogenase (GDH2) degrades glutamate to ammonia and α-ketoglutarate, 
it may indirectly participate in the demethylation of histone H3K4 through Jhd2p. 
        Of the five genes that were knocked out and crossed back to an rpd3 strain, only the bre1∆ 
and bre2∆ gene knockouts showed a loss of extended silencing at HMR. Interestingly, there was 
no loss of telomeric silencing in both the double knockout strains, as growth on 5-FOA (5-
flouro-orotic acid) demonstrated that the inserted URA3 gene proximal to telomeres was not 
expressed. BRE1 and BRE2 are both either indirectly or directly required for the trimethylation 
of H3K79 and H3K4, which is required for the proper regulation of silencing at HMR, rDNA, 
and telomeres (Fingerman, Wu et al. 2005). Our initial experimentation through ChIP assays did 
not show any differences in H3K4 trimethylation along the HMR region or regions downstream 
of HMR between WT and rpd3Δ strains.  
        Other studies involving histone H3K4 methylation have suggested that mutations in the 
methylation establishment pathway can lead to a re-distribution of Sir proteins at silenced loci 
(Tompa and Madhani 2007; Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009; 
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Ehrentraut, Weber et al. 2010). In light of this new evidence, we have modified our hypothesis of 
the rpd3∆ silencing effect to take into account the limited availability of Sir proteins in the cell. 
Our adjusted hypothesis includes the supposition that rpd3Δ strains result in an increase in the 
global acetylation of nucleosomes in euchromatic regions; this altered acetylation state can 
potentially cause a shift of the localization of the limited pool of Sir proteins, as their binding to 
some regions would be inhibited by acetylated histones, freeing them to concentrate at silenced 
telomeric and HMR regions. This adjusted hypothesis and the description of future studies, 
which will include the utilization of Sir proteins fused with a functionally repressed E. coli DNA 
methyltransferase, will be addressed in more detail in the final discussion chapter. 
MATERIALS AND METHODS 
All yeast strains used in this study are isogenic to W303-1a except where noted. The original 
parent rpd3Δ strain (DDY 3133) containing ADE2 downstream of HMR used for ultraviolet 
mutagenesis in the genetic screen was created previously in our lab as described (Jambunathan, 
Martinez et al. 2005). All oligonucleotides utilized in this study are listed in Table 2.1. 
Yeast Genomic DNA Extraction (Winston Prep)  
        A 4 mL yeast overnight culture was grown in YPD (Yeast extract Peptone Dextrose) media 
or YMD (Yeast Minimal Dextrose media if selecting for a plasmid) at 30ºC with rotation for 
aeration. The overnight culture was spun at 2000 rpm for 5 min. The supernatant was aspirated 
and the pellet was resuspended in 400 μL of Winston solution (2% Triton X-100, 1% SDS, 100 
mM NaCl, 10 mM Tris HCl pH8.0 and 1 mM EDTA). The cell suspension was then added to a 
microfuge tube containing ~300 μL of glass beads and 300 μL of phenol/chloroform. The 
samples were vortexed for 5 min in a multi-vortexer at high speed, spun for 5 min at high speed 
and the supernatant removed and added to another tube containing 300 μL of phenol/chloroform 
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for another extraction. The samples were then vortexed for ~15 sec and spun for another 5 min. 
The supernatant was removed and added to a tube containing 1 mL of absolute ethanol, mixed 
well and incubated at room temperature for 5-10 min. The samples were then spun for 10 min at 
room temperature or 4ºC and the ethanol was aspirated. The pellet was air-dried and resuspended 
in 80 μL of TE containing RNase A (60 μg/mL) 
Yeast High Efficiency Transformation  
        Yeast cultures were grown in YPD at 30ºC with constant shaking to an Optical Density 
(O.D.) at 600 nm of 0.7, and the pelleted cells were resuspended in 1X TEL (1 mL of 1X TEL 
per 10 mL culture) and were left to rock overnight at room temperature. The next day cells were 
pelleted, resuspended in 100 μL of 1X TEL per 10 mL culture incubated at room temperature for 
30 min. 100 μL of competent cells, 5 μL of 10 mg/mL Salmon sperm DNA and 1 μg of the 
plasmid DNA were mixed in an eppendorf tube and incubated again for 30 min. 700 μL of 40% 
PEG/TEL was added to each tube and incubated at room temperature for 60 min without 
shaking. 88 μL of DMSO was added to each tube, mixed and the cells were subjected to heat 
shock at 42ºC for 10 min. The cells were spun gently at 8000 rpm for 30 sec, pellets washed with 
300 μL of water and resuspended in 400 μL of water. 200 μL was plated on to two YM selection 
plates. 
Yeast RNA Extraction  
        A culture of 35 mL was grown to an optical density of 1.0. The cells were pelleted and 
washed with 1 mL of DEPC water and resuspended in 1 mL of extraction buffer (50 mM 
NaOAc, 10 mM EDTA, HOAC pH 5.0). 120 μL of 10% SDS was added and vortexed and cells 
were frozen at -80ºC. 1.2 mL of phenol equilibrated in NaOAc extraction buffer was prewarmed 
to 65ºC and added to the cells and mixed well. Samples were then incubated in a water bath set 
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at 65ºC with constant shaking for one hour and then cooled on ice for 5 min. The tubes were then 
spun for 10 min at high speed and the top aqueous layer was removed and re-extracted with 
another 1 mL of equilibrated phenol. Samples were spun again and the aqueous phase was 
extracted with 1 mL of phenol/chloroform equilibrated in ANE buffer (10 mM NaOAc, 100 mM 
NaCl, 1 mM EDTA pH 6.0). RNA was then precipitated with 1/10 volume of 3 M NaOAc and 
1.4 mL of absolute ethanol at -20ºC for 30 min to overnight. The RNA was pelleted by 
centrifugation for 10 min at 4ºC and washed with 300 μL of 70% ethanol (diluted in DEPC 
water), air dried and resuspended in 600 μL of DEPC water. Concentration (µg/µL) was 
determined by measuring UV absorbance at 260 nm. 
Northern Blot Analysis  
        Yeast cultures were grown in YPD and total RNA was extracted as described above. 10 μg 
of total RNA for each sample was resolved on a MOPS/formaldehyde/agarose gel and blotted to 
Zeta–Probe (Bio-Rad) membrane by wicking in transfer buffer (0.01 N NaOH + 3 M NaCl). 
PCR-generated double-stranded DNA containing the T7 promoter and region of homology to 
mRNA target was used as the template in the generation of a radioactive RNA antisense probe. 
The probes were 
32
P-α-UTP-labeled in a T7 polymerase in vitro transcription reaction at 37ºC for 
30 min to 1 hr. Zeta-probe membrane was incubated in ULTRAhyb (Ambion) for a pre-
hybridization step. The radioactive probe was filtered to remove unincorporated UTP and added 
to the membrane. Hybridization was carried out overnight at 65ºC. Membranes were washed 
twice in 2X SSC for 5 min each in 65ºC, then washed twice in 0.1X SSC for 15 min each in 
65ºC. Zeta-probe membrane was then placed under phosphor screen in exposure cassette for 2 hr 
to overnight and scanned using Typhoon scanner (LSU Genomics Facility). The PCR-generated 
double-stranded DNA used to generate the RNA probes are as follows: PNC1 (DDO 898/899), 
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NPT1 (DDO 900/901), QNS1 (DDO 906/907), NMA1 (DDO 902/903), and NMA2 (DDO 
904/905). 
Genetic Screen of UV-mutated rpd3Δ Strains 
        For the genetic screen, rpd3Δ cells (DDY 3133) were diluted and plated on YPD media for 
single cells and subjected to 12 sec doses of 200 µJ of ultraviolet light to initiate random 
mutations in the yeast genome of each plated cell. After two days of growth on YPD, white 
colonies were isolated and used for the library transformation to complement and identify the 
mutated genes. 250 ng of genomic library plasmid DNA (total conc. 0.84 µg/µL), containing a 
yeast LEU2 marker and a bacterial AMP-resistant (AMP
r
) gene (Courtesy of J. Rine) was 
transformed by high efficiency yeast transformation (see described) to produce ~500 colonies 
plated on YMD –leu, 30% adenine. Approximately 6000 colonies were screened for each round 
of transformations. The transformed cells were plated on YMD –leu, 30% adenine to produce 
optimal red/pink pigmented colonies if the ADE2 gene is silenced. Twenty-four high efficiency 
transformations of the library plasmid were performed and two transformations were plated on 
100 mm plates (12 total), including one negative control plate with no plasmid DNA. The 
red/pink colonies were patched to –leu 30% ADE, -leu, -ura (for URA3 marker at the telomere), 
and 5-FOA (5-flouroorotic acid) + all mix (growth due to silencing of URA3) plates. Positive 
growth patches were inoculated in YMD –leu, 30% ADE and yeast genomic DNA extracted (See 
Winston prep described). Yeast total DNA was cleaned and eluted in 50 µL water using PCR-
clean up kit (Zymo #D4003). 3 µL of yeast total DNA (containing library plasmid) was 
electroporated (2.5 kV, 25 µF, 200 Ω) into 40 µL of electrocompetent E. coli (DH5α) and plated 
on 2xyt+ampicillin bacterial media. Library plasmid DNA was extracted from ampicillin-
resistant bacteria colonies (alkaline lysis miniprep) and recovered plasmid was digested with 
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EcoRI to detect restriction patterns different from those of previously recovered library plasmids 
containing normal heterochromatin-complementing genes such as SIR2, SIR3, etc. Recovered 
plasmids containing potential effector open reading frames (ORFs) were re-transformed back 
into the original UV-mutated strain they were first transformed into and analyzed for 
complementation by the phenotypic change of colony color from white (mutated effector) to 
red/pink (complement gene). Plasmids with positive complementation were then sequenced 
(LSU Genomics Facility) using plasmid-specific primers (DDO 821/822) and the sequences 
were BLAST searched through the SGD (Saccharomyces Genome Database) (Guldener, 
Munsterkotter et al. 2005).  
Gene Knockouts (LEU2 Replacements) 
        Gene Knockouts were generated by first PCR amplifying LEU2 from plasmid template 
pDD672 with primers having regions of homology to both the plasmid carrying the LEU2 gene, 
and the flanking regions of the genes being deleted. Eight PCR reactions containing the 2.3 kb 
LEU2 PCR product were verified by gel electrophoresis and purified using PCR clean-up kit 
(Qiagen). The linear double-stranded DNA carrying the LEU2 gene was transformed into DDY 
3161 and 3160 by high efficiency transformation as described. Cells were plated on YMD -leu to 
select for positive LEU2 integrants. DNA was extracted from Leu+ isolates and checked for 
proper integration by upstream and downstream PCR. DDO oligos for PCR check for upstream 
and downstream integration: BRE1 (914/198) and (915/199), GDH2 (918/198) and (919/199), 
BRE2 (927/198) and (928/199), GAT3 (931/198) and (932/199), RXT3 (935/198) and (936/199); 
198 and 199 were interchanged with 823 and 824 (Table 2.1). 
        Plasmid Gap Repair of wild-type and UV-mutated BRE1 and BRE2 alleles were generated 
by PCR-amplified upstream and downstream genomic ends: BRE1 (DDO 1007/1008) Up and 
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(DDO 1009/1010) Down, BRE2 (DDO 1016/1017) Up and (DDO 1018/1019) Down in parent 
strain DDY3. Amplified PCR products from both up and downstream for both genes were 
digested with Pac I at the integrated site. The upstream fragment for both genes was also 
digested with Sal I. The downstream fragment for BRE1 was digested with Xba I and the 
downstream fragment for BRE2 was digested with Not I. All restriction sites were integrated 
through PCR amplification of the genomic ends. The upstream and downstream fragments for 
BRE1 were ligated into pCR2.1 (TOPO-Invitrogen) and subcloned into pDD637 (LEU2). The 
upstream and downstream fragments for BRE2 were ligated into pCR4 (TOPO-Invitrogen) and 
subcloned into pDD637. Both pCR2.1 and pCR4 were double-digested with Sal I/Xba I for 
ligation of the BRE1 fragments (into pCR2.1) and Sal I/Not I for ligation of the BRE2 fragments 
(into pCR4); both inserts were then subcloned into pDD637, which generated new plasmids, 
pDD1163 and pDD1165. Both plasmids (1163 and 1165) were digested with Pac I to linearize 
the DNA and transformed into DDY 3 to rescue the wild-type allele by gap repair recombination 
(Orr-Weaver and Szostak 1983). The newly generated BRE1 plasmid (pDD1166) was 
transformed into UV-mutated strain DDY 3883 to verify rescue of the UV induced mutation, and 
the BRE2 plasmid was transformed into DDY3971. 
Chromatin Immunoprecipitation Assays  
        Chromatin Immunoprecipitation (ChIP) was done according to (Kuo and Allis 1999). Wild-
type and rpd3Δ cultures were grown in YPD to an optical density of 1.5 at 600 nm. The cells 
were then fixed with 3.25 mL of 37% formaldehyde (Fisher #F79-1) and incubated at room 
temperature for 20 min with gentle swirling. Cells were pelleted and washed once with 10 mL of 
1X Phosphate Buffered Saline (PBS) (pH 7.4). Cells were resuspended in lysis buffer (50 mM 
HEPES-KOH, pH 7.5, 140 mM NaCl, 1% Triton X-100 and 0.1% Sodium deoxycholate) 
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containing the protease inhibitors, pepstatin A (1 μg/mL), leupeptin (1 μg/mL) and PMSF (100 
mM), and then lysed by vortexing with glass beads for 40 min at 4ºC. The lysate tube was then 
placed into another open tube containing 10 µL of PMSF by poking the bottom of the sample 
tube containing glass beads with a hot 0.5 gauge needle, spun for a few seconds and collected 
into the new tube. To fragment the chromatin to suitable immunoprecipitate size (200-1000 bp), 
the lysate was sonicated six times for 10 sec each at 25% amplitude (Branson sonicator) with 0.9 
sec intermittent pulses for a total of 10 sec and keeping the samples on ice ~1 min between 
sonication cycles. The samples were then spun at 13,200 rpm for 10 min in 4ºC to pellet 
insoluble material. The supernatant containing soluble chromatin was collected as whole cell 
extract (WCE) and used for further analysis. 100 μL of lysate was mixed with 300 μL of lysis 
buffer containing the protease inhibitors. Then the mixture was incubated in protein A sepharose 
beads (Amersham Biosciences), that were washed thrice with lysis buffer containing protease 
inhibitors and resuspended in lysis buffer containing 200 μg/mL of salmon sperm DNA and 500 
μg/mL BSA, and rocked for 30 min at 4ºC. The beads were then spun out and 5 μL of antibody 
(H3K4me3) (Abcam #ab8580-100, ~1 mg/mL) was added to the supernatant. The samples were 
incubated overnight at 4ºC with gentle rocking. The antibody reactions were spun and the 
supernatant was transferred to fresh tubes. 30 μL of washed and equilibrated beads was added 
and the samples were incubated at 4ºC for 1 hour on a rotating nutator to pull down the antibody-
bound H3K4me3 histone proteins cross-linked to their respective DNA locus. The tubes were 
spun again and the supernatant was transferred to fresh tubes as unbound fractions. The beads 
were washed for 5 min each with 1 mL of the following buffers: i) Lysis buffer with protease 
inhibitors, ii) Wash buffer I (Lysis buffer + 500 mM NaCl), iii) Wash buffer II (10 mM Tris 8.0, 
250 mM LiCl, 0.5% NP-40, 0.5% Sodium Deoxycholate, 1 mM EDTA), and iv) TE (1X). After 
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TE wash, the tubes were spun again to remove any residual liquid. After this step, an efficient 
and rapid Chelex-resin based procedure was used to isolate PCR-ready DNA (Nelson, Denisenko 
et al. 2006). This method utilizes 100 μL of 10% Chelex-100 (10 g/100 mL H2O, Bio-Rad) 
added to the washed protein A beads and vortexed. Samples were boiled for 10 min, cooled, and 
1 μL of Proteinase K (100 μg/mL) was added and the beads were incubated for 30min at 55C 
while shaking, then boiled for another 10min. The suspension was centrifuged and the 
supernatant was collected. The Chelex/protein A beads fraction was vortexed with another 100 
μL water, centrifuged again, and the supernatant was combined with the previous supernatant. 
The eluate was used directly in the PCR reaction. For input controls 10 μL of the whole cell 
extract was mixed with 475 μL of Elution buffer (1% SDS, 0.1 M NaHCO3), and 20 μL of 5 M 
NaCl. The tubes were incubated at 65ºC (four hours to overnight) to reverse the protein/DNA 
crosslinks. To each tube 20 μL of 1M Tris pH 8.0, 10 μL of 0.5 M EDTA and 1 μL of Roche 
Proteinase K (20 mg/mL) was added and incubated at 55ºC for 30 min. The sample was 
extracted once with phenol/chloroform, and then precipitated in 50 μL of NaOAc, 1 μL of 
glycogen (Roche, 20 mg/mL stock), and 1 mL of absolute ethanol and precipitated at -20ºC. The 
samples were then spun at 4ºC for 10 min and the pellets washed with 300 μL of 70% ethanol, 
air dried and redissolved in 200 μL TE + RNaseA (60 μg/mL). 
Table 2.1. Oligos used in this study: 
Oligo   Sequence 
 
DDO 59   5’-GAATTCGTTAACGGATCCCATACTCGAAGGGTAGTTGG-3’ – tRNA Up 
DDO 60   5’-GAATTCGTTAACGGATCCGATTTTTCCATTCGCCATGC-3’ – tRNA Down 
DDO 184   5’-GTAATACGACTCACTATAGGGC-3’ – T7 Primer 
DDO 198   5’-GCACTCTCAGTACAATCTGC-3’ - pRS universal RC, upstream 
DDO 199   5’-CCGCACAGATGCGTAAGGAG-3’ - pRS universal RC, downstream 
DDO 478   5’-TGACTAAAGTAGAGCAACATACATT-3’ – HMR B-1    
DDO 479   5’-TCTCATACGTTTATTTATGAACTAC-3’ – HMR B-2 
DDO 480   5’-TCAATGATTAAAATAGCATAGTCGG-3’ – HMR C-1 
DDO 481   5’-CAATAGCAATTGTATAAACACATAG-3’ – HMR C-2 
DDO 482   5’-GGCGATATAATTTATCATGTTTTGG-3’ – HMR D-1 
DDO 483   5’-TCTCTAACTTCGTTGACAAATTTTC-3’ – HMR D-2 
DDO 484   5’-CCAATTCCGCATCTGCAGATTACTT-3’ – HMR-tDNA-E1 
(Table 2.1 continued) 
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DDO 485   5’-TTCATTATTTTTCAGATGACGATGG-3’ – HMR-tDNA-E2 
DDO 595   5’-CCGTCCAAGTTATGAGCTTA-3’ - HMR A-1 
DDO 596   5’-GCCTACCTTCTTGAACAAGA-3’ - HMR A-2       
DDO 821   5’-ATTTCTATGCGCACCCGTTC-3’ - pBR322 Bam HI site sequencing fwd 
DDO 822   5’-AAGTGGCGAGCCCGATCTTC-3’ - pBR322 Bam HI site sequencing rev (230 BP APART) 
DDO 823   5’-ATCTTCTTAGGGGCAGACAT-3’ - LEU2 upstream CDS 
DDO 824   5’-GAAGTTAAGAAAATCCTTGCTTA-3’ - LEU2 downstream CDS 
DDO 901   5’-TAATACGACTCACTATAGGTTCACAGCTTTCATGATTCCTTG-3’ - NPT1 T7 
DDO 902   5’-ATGGATCCCACAAGAGCTCCG-3’ - NMA1 Northern 
DDO 903   5’-TAATACGACTCACTATAGGACTTCAAACCTTGTTTGTTCAG-3’ - NMA1 T7 
DDO 904   5’-ATGGATCCCACCAAAGCACCC-3’ - NMA2 Northern 
DDO 905   5’-TAATACGACTCACTATAGAGAAAAATAACCACCAACCACTTC-3’ - NMA2 T7 
DDO 906   5’-ATGTCACATCTTATCACTTTAGC-3’ - QNS1 Northern 
DDO 907   5’-TAATACGACTCACTATAGAGATGAGTTTGTCATGATTTCCAC-3’ - QNS1 T7 
DDO 912 5’-AGGGCTTTCACCGTTTTTATGCTAATCGTGCTAGCTGATAATAATCAGATGCAGATTGTACTGAGAGTGC-3’- 
BRE1 PRS KO UPSTREAM 
DDO 913 5’-TATGTGGAGGATATAACACAAACAGTGGAAAAGTGGTAGAATAATTAGTACTTCTTACGCATCTGTGCGG-3’- 
BRE1 PRS KO DOWNSTREAM 
DDO 914   5’-AATATTGGGAAAATCACTGGTG-3’ - BRE1 KO UPSTREAM CHECK 386 BP 
DDO 915   5’-GAACAAGCGCGATTAAGGTC-3’ - BRE1 KO DOWNSTREAM CHECK 327 BP 
DDO 916 5’-AAACATACAAAACAAGGATATTAAATTCACAACAATAAAAAGAATAAAGAGCAGATTGTACTGAGAGTGC-3’- 
GDH2 PRS KO UPSTREAM 
DDO 917 5’-TTTCTTTTCTGACGGCAGAACTAATTTATACAAAACAATTTTATTGAAGCCTCCTTACGCATCTGTGCGG-3’- 
GDH2 PRS KO DOWNSTREAM 
DDO 918   5’-AAACCAAGTCCGCTTGAAAAG -3’ - GDH2 KO UPSTREAM CHECK 398 BP 
DDO 919   5’-ACGGCTTGAATCGCATACTTG -3’ - GDH2 KO DOWNSTREAM CHECK 450 BP 
DDO 925 5’-GATAAAGGTGGCCATAATTGGACGAAGACAAATAATTCACTTCCTTAATAGCAGATTGTACTGAGAGTGC-3’- 
BRE2 PRS KO UPSTREAM 
DDO 926 5’-TAAGAAACACACTTTCAGTGTGTTTTAATTATTCTTCTTTGAATGCTGCTCTCCTTACGCATCTGTGCGG-3’-  
BRE2 PRS KO DOWNSTREAM 
DDO 927   5’-CAATCGACATCGTTTACATGCAG-3’ - BRE2 KO UPSTREAM CHECK 380 BP 
DDO 928   5’-AGGAGCTGTTATTTAGTCGGTCG-3’ - BRE2 KO DOWNSTREAM CHECK 390 BP 
DDO 929 5’-AAACAATTATCAACTAGAAGCAAATATAAAGCCAGAAGGAAGAATTTGCTGCAGATTGTACTGAGAGTGC-3’- 
GAT3 PRS KO UPSTREAM 
DDO 930 5’-ATCACTGCTTTGACATAAGTATATAACATTCCGAGCAGAAATAAATTCTCCTCCTTACGCATCTGTGCGG-3’- 
GAT3 PRS KO DOWNSTREAM 
DDO 931   5’-CATACTCACACAAACACCTGTAG-3’ - GAT3 KO UPSTREAM CHECK 426 BP 
DDO 932   5’-TGATAGAAGCAACAGTCCATTGAG-3’ - GAT3 KO DOWNSTREAM CHECK 350 BP 
DDO 933 5’-TACTCGCAGTTTTTTTTTTGAGAGAAGTAACAATACAATATAAGATAAAAGCAGATTGTACTGAGAGTGC-3’- 
RXT3 PRS KO UPSTREAM 
DDO 934 5’-GCCAACTAAGGTTGGAAGGGAAAGAAGGACGACCAATATTATGTCTTTCCCTCCTTACGCATCTGTGCGG-3’- 
RXT3 PRS KO DOWNSTREAM 
DDO 935   5’-ACTGTCCACGAAGGCAGATTGTC-3’ - RXT3 KO UPSTREAM CHECK 371 BP 
DDO 936   5’-ATATCGTTTACTACCGATTCGG-3’ - RXT3 KO DOWNSTREAM CHECK 365 BP 
DDO 1007 5’-AGAAATCAAAATGTCGACGTTTGTTATGCAATGAATGGTCAG-3’-BRE1 GAP 5'SAL I 
DDO 1008 5’-GATCATATTGCTTTAATTAAATGGGTCCTGCCATACATAATC-3’-BRE1 GAP 5'PAC I 
DDO 1009 5’-CTAACTTCTGAATTAATTAATGACGTCTACTGTCGCATGTTTC-3’-BRE1 GAP 3'PAC I 
DDO 1010 5’-CATAATTCATTCGCTCTAGACAAAACATAGAGCAGCAAGAAGC-3’-BRE1 GAP 3'XBA I 
DDO 1011   5’-CACCAGTGATTTTCCCAATATTATC-3’ - BRE1 GAP REPAIR CHECK WITH T7 ~670 BP 
DDO 1016 5’-TTCCGCTCTTGCGTCGACAGTCATAGGGCTGCCTGTCTC-3’ - BRE2 GAP REPAIR 5'SAL I 
DDO 1017 5’-TTCTCCTAATATTTAATTAACCAAATCTAGAACTGCATGTAAAC-3’-BRE2 GAP 5'PAC I 
DDO 1018 5’-GGTTATACATTCTTAATTAAGAGTTCGTAATCGTTATCTTCTTC-3’ - BRE2 GAP 3'PAC I 
DDO 1019 5’-GCTATTTCTCCAGCGGCCGCCATGGATATGCTAGGACTGGAG-3 - BRE2 GAP 3'NOT I 
DDO 1020 5’-ATAGAACAGATTTATCAAAAAGAGGAG -3’ - BRE2 GAP REPAIR CHECK WITH T7 ~600 BP 
DDO 1025   5’-AGATCTCTTACGGCTTATGATTG-3’ - HMR AT ADE2 JUNCTION – F1 
DDO 1026   5’-TGTCTTTGATTCTTTTAAGAAAAG -3’ - ADE2 CHIP WITH 1025 – F2 
DDO 1027   5’-CATAACACTGACATCTTTAACAAC -3’ - ADE2 START CODON CHIP WITH 1028 – G1 
DDO 1028   5’-CTAATATACCAACTGTTCTAGAATC-3’ - ADE2 START CODON CHIP WITH 1027 – G2 
DDO 1029   5’-GATTCTAGAACAGTTGGTATATTAG-3’ - ADE2 INTRAGENIC CHIP WITH 1030 – H1 
DDO 1030   5’-CAATCTGATTGTTTCTGGAGAAG-3’ - ADE2 INTRAGENIC CHIP WITH 1029 – H2 
 
 
RESULTS 
Genetic Screen of Genomic Library Transformed Into Ultraviolet-Mutated rpd3∆ Strains. 
        RPD3 deleted strains exhibit a red pigment phenotype due to the ectopic silencing of a 
downstream ADE2 marker gene. This marker gives an indication of whether or not silencing has 
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spread from HMR through the tRNA barrier element to repress ADE2 expression and can be 
optimally assessed by growth on minimal media with 15-30% adenine supplement (Figure 2.1).  
 
 
 
 
 
 
Figure 2.1. Visual and schematic representations comparing the wild-type and rpd3Δ 
colony color phenotype. Wild-type colonies of Saccharomyces typically show a white to cream 
color demonstrating that the spread of silencing heterochromatin from the silencer sequences at 
HMR is halted at the tRNA
thr
 barrier allowing the inserted downstream ADE2 gene to be 
expressed. rpd3Δ colonies repress expression of the inserted downstream ADE2 gene and can 
display a pink to a much darker red color depending on the degree of silencing of the ADE2 gene 
in each cell of the colony and the free adenine available in the growth media. The strains shown 
are DDY 3136 (WT) and DDY 3133 (rpd3Δ). 
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We also assessed effects of silencing at the telomeres, as the HMR-ADE2 strain also contained an 
inserted URA3 marker on chromosome VII proximal to the telomere ends. URA3 expression was 
assessed by growth on minimal media containing 5-FOA (Boeke, LaCroute et al. 1984). 
Subjecting rpd3∆ strains with doses of UV-radiation typically induces random mutations in the 
yeast genome such as point mutations and pyrimidine dimers. Phenotypical analysis of any such 
mutations that would cause a loss-of-function in a potential effector of the increased silencing 
effect should show a reversion of colony color from the red/pink of rpd3Δ to the wild-type 
white/cream.  
        For establishing these random mutations across the yeast genome, rpd3Δ cells (DDY 3133) 
were spread on YPD plates for the growth of isogenic yeast colonies derived from a single 
colony. The plates were then exposed to 200 µJ of ultraviolet light for ~20 sec. Nine YPD plates 
with rpd3Δ cells were treated with ultraviolet light and three were untreated control plates. After 
UV exposure and growth at 30ºC for two days, colonies containing mutations resulting in 
reversion from the red colony color to the white colony color phenotype were isolated. UV-
mutagenesis produced 27 isolates (white colonies) from rpd3Δ strains after screening over 
20,000 colonies. The colony isolates change to a white color was verified by second streaks on 
YPD media and YMD+all with 30% adenine. 
        Individual mutated isolates were then transformed with a genomic plasmid library by high 
efficiency transformation (see Methods) and plated on YMD -leu to select for cells containing 
the library plasmids and grown at 30ºC for two to three days. Colony growth analysis was to 
strictly observe any growing colonies that had reverted back to the original red colony color 
phenotype, suggesting either complementation or suppression of the UV induced mutation. The 
genomic library plasmids contained average insert sizes of 8-12 kb. Because of the compact 
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nature of the yeast genome, each plasmid contained multiple ORFs, thus verification of potential 
ORFs would require analysis of individual genes contained on each plasmid. 18 out of the 27 
white colony revertant UV-mutated strains exhibited red colony isolates after transformation of 
the genomic plasmid library after screening >12,000 colonies per strain transformed (Table 2.2). 
 
 
 
 
 
 
        The newly transformed colonies exhibiting red colony color were isolated and the 
transformed plasmid containing the potential effector was recovered through yeast DNA 
extraction (Winston prep - see Methods). To recover the library plasmid, the Winston prep DNA 
was electroporated into E. coli for plasmid amplification and subsequent analysis. The genomic 
Listed are the 18 HMR-ADE2 UV-mutated rpd3∆ strains (white) that, upon genomic library 
transformation, gave rise to isolates that had reverted to the original rpd3∆ colony color 
phenotype (pink). After plasmid rescue, the plasmid inserts were sequenced and analyzed for any 
genes that were potentially involved in the silencing effect. The genotype of each strain is 
isogenic and listed in Table 2.4. 
Table 2.2. UV-mutated rpd3∆ strains transformed with potential effector genes from 
genomic library plasmids.   
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library plasmids contained an ampicillin resistant gene which was used to select for E. coli cells 
that had retained the library plasmid on 2xyt+ampicillin bacterial media. After DNA extraction 
from the E. coli cells, the candidate library plasmid was subjected to restriction analysis using 
EcoRI and known sites in the plasmid vector to analyze any unique restriction patterns that 
differed from what was seen from recovered plasmids that contained any normal 
heterochromatin-complementing genes such as SIR2, SIR3, etc. The library plasmids were then 
sequenced using library plasmid-specific primers (DDO 821-Up and DDO 822-Down) to 
determine if any ORFs within the plasmid insert could be directly or indirectly responsible for 
participating in the silencing effect or the establishment of heterochromatin. The recovered 
plasmid insert sequences were BLAST (Basic Local Alignment Search Tool) searched using the 
Saccharomyces Genome Database (SGD) (Guldener, Munsterkotter et al. 2005).  
        We identified seven genes outside the normal heterochromatin-forming complement that 
were highly ranked as potential effectors of the silencing effect. These genes were BRE1, BRE2, 
GDH2, GAT3, RXT3, QNS1, and NPT1. Table 2.2 lists the 18 white colony strains with the 
number of revertants (minipreps) for each set of transformations. Any isolate containing a 
potential effector listed in red was used for complementation analysis. As expected in this 
particular genetic screen, we identified a number of recovered plasmids containing SIR genes, 
mainly SIR3 and SIR4, a few of which are also listed in Table 2.2. Each of the seven genes 
identified in the genetic screen are functionally described as follows: QNS1 - glutamine-
dependent NAD
+
 synthetase; NPT1 - nicotinate phosphoribosyltransferase, acts in salvage 
pathway of NAD
+
 biosynthesis; BRE1 - E3 ubiquitin ligase for Rad6p, required for the 
recruitment of Rad6p to promoter chromatin and ubiquitylation of histone H2B on K123; 
H2BK123 ubiquitylation is required for subsequent methylation of histone H3 (K4 and K79); 
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GDH2 – NAD+-dependent glutamate dehydrogenase, which converts glutamate to α-
ketoglutarate; BRE2 - Subunit of the COMPASS (Set1c) complex, which methylates histone 
H3K4; GAT3 - Protein containing GATA family zinc finger motifs (transcription factor activity); 
RXT3 - Subunit of Rpd3(L) complex; contributes to histone deacetylase activity and 
transcriptional repression.  
        QNS1, glutamine-dependent NAD
+
 synthetase, was recovered in three separate isolates after 
library plasmid transformation and NPT1, nicotinate phosphoribosyltransferase, was found in 
one. Also found in the genetic screen were two isolates of BRE1, E3 ubiquitin ligase for Rad6p, 
four isolates of BRE2, subunit of the COMPASS (Set1c) complex, two isolates of GDH2, NAD
+
-
dependent glutamate dehydrogenase, three isolates of GAT3, GATA family zinc finger motifs, 
and two isolates of RXT3, subunit of Rpd3(L) complex. BRE2 and GAT3 are two genes which 
are in close approximation to each other (~2 kb) in the S.cerevisiae genome and two isolates 
recovered contained both ORFs. BRE2 and GAT3 were individually identified as effectors since 
we recovered two independent plasmid isolates containing only the BRE2 ORF and one 
independent plasmid isolate containing only the GAT3 ORF. For complementation analysis, all 
library plasmids that were recovered and identified as having potential effectors were re-
transformed back into their original UV-mutated rpd3Δ strain (white colonies). All strains, after 
plasmid complementation, showed a colony color phenotype change from white to red, thus 
further verifying that the recovered library plasmids contained genes that were potential 
effectors.  
Northern Analysis of NAD
+
 Biosynthesis Genes in Wild-Type vs. rpd3Δ Cells 
        Since we identified multiple genes that potentially affect NAD
+ 
levels in cells, we pursued 
this class of genes first. The deacetylation reaction of H4K16 by Sir2p, and thus the propagation 
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of silencing, relies on the cofactor nicotinamide adenine dinucleotide (NAD
+
) to catalyze the 
deacetylation reaction (Imai, Armstrong et al. 2000; Landry, Slama et al. 2000; Smith, 
Brachmann et al. 2000). Two of the genes identified in the genetic screen, QNS1 and NPT1, are 
components of the NAD
+
 biosynthesis pathway. Since the NAD
+
-coupled Sir2p deacetylase 
reaction is the foundation of heterochromatic silencing at HMR, we hypothesized that RPD3 
could either be directly or indirectly involved in the regulation of these pathway genes and thus 
the expression of these two genes may affect Sir2p activity. The rationale is that Rpd3p may 
function as a repressor of QNS1 or NPT1 expression at their own promoters and thus the deletion 
of RPD3 may enhance the expression of these genes which can result in increased availability of 
NAD
+
 as a cofactor for the enzymatic action of Sir2p at the HMR region.  
        We performed a Northern analysis on the two genes identified in the screen, QNS1 and 
NPT1, and included the gene PNC1 which is responsible for the conversion of nicotinamide to 
nicotinic acid and thus the clearance of nicotinamide (a product of the Sir2p deacetylase 
reaction) which can inhibit the enzymatic action of Sir2p.  
 
 
         
 
        As shown in the Northern blot analysis (Figure 2.2), the mRNA expression of the genes 
QNS1, PNC1, and NPT1 showed no reproducible difference between wild-type (DDY 3 and 4) 
Figure 2.2. Northern analysis of NAD
+
 biosynthesis pathway genes in wild-type vs. rpd3Δ 
cells. NAD
+
 pathway genes identified in the genetic screen were analyzed for differential gene 
expression based on Sir2p dependence on NAD
+
 for its proper function. Probes generated for 
mRNAs of QNS1, PNC1, and NPT1 showed no reproducible qualitative difference in gene 
expression in wild-type vs. rpd3Δ cells. Actin (ACT1) was used as an input control. 
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and rpd3Δ (DDY 3018 and 3021) strains even after three replications of the Northern 
experiment. The Northern assay was also repeated in three replicates using different rpd3Δ 
laboratory strains, DDY 1671 and 1677, and no difference in expression was noted between WT 
and rpd3Δ. These consistent null results were also seen in Northern analyses of the genes NMA1, 
NMA2, QPT1 (involved in the NAD
+
 de novo pathway), and TNA1 (involved in the NAD
+
 
salvage pathway – nicotinic acid plasma membrane permease) (data not shown). The expression 
of ACT1 (Actin) was used as an input (loading) control for all Northern analyses. The five 
remaining genes identified in the genetic screen were knocked out and subjected to genetic, 
phenotypic, and complementation analysis. 
Genomic Knockouts of BRE1, BRE2, GDH2, GAT3, and RXT3 and rpd3Δ Cross Analysis 
        The original UV-mutated strains (white colonies) which contained random mutations in 
potential effector genes may or may not have had a complete loss-of-function. Such mutations 
can result in partially truncated proteins with a range of lower-end activity and high turnover 
rates, but not necessarily a complete loss-of-function. To verify that the five remaining genes 
were bona-fide effectors, the complete ORFs of each gene were individually knocked out and 
replaced with a LEU2 gene marker. This complete knockout of the coding sequence would 
insure that there was a complete loss-of-function of the potential effector genes. The analysis 
was to assess if each individual gene knockout, when crossed to an rpd3Δ strain, would derepress 
expression of the ADE2 gene and result in a colony color phenotype from red (rpd3Δ) to white 
(rpd3ΔmutX).  
        As exemplified in Figure 2.3, the question remains if the potential effector is directly 
involved in contributing to the integrity of the tRNA barrier element or if the effects are indirect 
and results in a gradual loss of silencing before reaching the ADE2 gene. The five separate gene 
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knockouts were generated through transformation of linear double-stranded DNA containing a 
functional LEU2 gene and regions of homology to the target loci on both the 5’ and 3’ ends of 
the DNA duplex into strain DDY 3161. 
 
         
 
 
         
The oligonucleotides used for amplifying the LEU2 gene for each knockout were as follows: 
BRE1 (912/913), GDH2 (916/917), BRE2 (925/926), GAT3 (929/930), and RXT3 (933/934). The 
PCR-amplified linear DNA was transformed using high efficiency transformation (see Methods). 
Gene integrations of LEU2 for the BRE1 locus and the RXT3 locus were verified by upstream 
and downstream PCR. BRE2, GAT3, and GDH2 were verified by Southern blotting. Each newly 
created strain carrying one knock out each of the five genes assayed (BRE1, BRE2, GAT3, RXT3, 
Figure 2.3. Schematic representation of the HMR region, tRNA barrier element and 
inserted ADE2 gene. rpd3Δ strains enhance silencing from HMR downstream to the ADE2 gene. 
Our hypothesis states that mutating (or deleting) a potential effector gene in the rpd3Δ 
background will abolish the spread of silencing in the double mutant and the ADE2 gene will be 
expressed. Whether or not the effector contributes to the integrity of the barrier element or 
influences the robustness of silencing remains to be answered. 
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and GDH2) were subsequently crossed to an rpd3Δ (DDY 3155) strain and analyzed for colony 
color phenotype change in the double mutants.  
 
 
 
 
        Of the five strains assayed with individual genes deleted, only strains containing mutated 
BRE1 or BRE2, when crossed with an rpd3Δ strain, showed a significant change in colony color 
phenotype from red to white, thus abolishing the enhanced silencing effect of rpd3Δ at HMR 
(Figure 2.4). The individual gene knockouts of GDH2, GAT3, and RXT3 all exhibited no 
phenotype change (red to white) when crossed to the rpd3Δ background indicating that UV 
mutagenesis did not produce a complete loss-of-function in these three genes. The bre1Δrpd3Δ 
Figure 2.4. BRE1 and BRE2 are effectors of the rpd3Δ silencing effect. Knockouts of either 
BRE1 or BRE2 in an rpd3Δ background halted the spread of silencing past the tRNA barrier to 
the downstream inserted ADE2 gene. The colony color phenotype was reverted from a dark red 
colony color in the rpd3Δ strain to a white colony color in both the bre1Δrpd3Δ and 
bre2Δrpd3Δ strains. 
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and bre2Δrpd3Δ phenotype change was verified in complementation assays by transforming the 
plasmids containing the BRE1 and BRE2 coding sequences back into the double knockout strains 
bre1Δrpd3Δ and bre2Δrpd3Δ, respectively. The plasmids used for complementation were the 
original plasmids obtained from the genomic library that contained the BRE1 and BRE2 ORFs in 
the ~10 kb insert. Since the original library plasmids contained more than one potential ORF 
(e.g. some library inserts contained both BRE2 and GAT3), we had to verify that BRE1 and BRE2 
were the only genes (coding sequences) responsible for complementation of the rpd3∆ silencing 
effect. We separately transformed laboratory-generated cloned plasmids containing the coding 
sequence of wild-type BRE1 and BRE2 which were generated by gap repair techniques (see 
Methods – Gene Knockouts) from wild-type strains. The individual bre1∆ or bre2∆ knockout 
strains (no rpd3Δ background) created did not have any effect on the colony color phenotype 
compared to WT (all white) which establishes bre1Δ and bre2Δ epistatic to rpd3Δ in a regulatory 
pathway. 
        When analyzing enhanced silencing at the telomeres with WT, rpd3Δ, and our generated 
knockout strains, including the double mutants, we took advantage of an inserted URA3 at the 
telomeres for a growth marker and assayed for degrees of growth or non-growth on both YMD 
minus uracil and 5-FOA+all mix. Silencing at the telomere on chromosome VII-L showed nearly 
the same consistency of silencing as seen at the HMR region between WT and rpd3Δ strains. In 
WT cells, there was growth on minus uracil but no growth on 5-FOA. In rpd3Δ strains, there was 
no growth on minus uracil but growth on 5-FOA due to silencing of the URA3 gene at the 
telomere (Table 2.3). The bre1Δ mutant grew slightly more on 5-FOA+all mix compared to WT 
and showed less growth on minus uracil compared to WT indicating that BRE1 is potentially 
contributing to silencing at the telomeres. The rpd3Δ strain showed an expected extended 
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silencing at the telomeres with no growth on minus uracil and full growth on 5-FOA+all mix. 
The bre1Δrpd3Δ double mutant rescued partial growth on minus uracil, while there was full 
growth on 5-FOA+ all mix, suggesting partial de-repression of telomeric silencing.  
 
 
 
 
 
The bre2Δrpd3Δ double mutant had very little growth on minus uracil similar to rpd3Δ and full 
growth on 5-FOA+all, suggesting a very weak de-repression of telomeric silencing. The bre2Δ 
mutant showed very little growth on minus uracil and the growth on 5-FOA+all was similar to its 
double mutant of bre2Δrpd3Δ. These results indicate that the mutants, bre1Δ and bre2Δ in the 
rpd3Δ background, do not halt the spread of silencing at telomeres to the extent the same 
HMR and telomeric silencing was assessed through phenotypical analysis of colony color in three 
separate isolates grown on YMD 15% adenine (HMR), YMD -ura (telomere), and growth on 5-
FOA+all (telomere). Colony color on 15% adenine – white (ADE2 expressed) or pink (ADE2 
repressed), - no growth, +very little growth, ++spotty growth, +++more growth, ++++full growth 
Table 2.3. Phenotypic analysis of silencing at telomere region (URA3) on chromosome VII-L. 
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mutations do at HMR. Interestingly, based on these initial results, BRE1 may play a role in 
silencing at the telomeres, while BRE2 seems to have no significant effect. 
ChIP (Chromatin Immunoprecipitation) of H3K4me3 at HMR in WT vs. rpd3Δ 
        BRE1 encodes the E3 ubiquitin ligase for Rad6p (E2), which in an E2-E3 complex together 
is recruited to promoter regions and ubiquitylates histone H2B on K123. This ubiquitylation is 
required for the subsequent trimethylation of histone H3K4 by Set1p and H3K79 by Dot1p. 
Set1p is the catalytic subunit of the COMPASS complex which mono-, di-, or tri-methylates 
H3K4. Trimethylation of H3K4 is normally associated with active transcription, particularly in 
the coding regions of genes (Bernstein, Humphrey et al. 2002; Santos-Rosa, Schneider et al. 
2002). BRE2 encodes a functional subunit of the COMPASS (Set1p) complex. Since both BRE1 
and BRE2 are either directly or indirectly involved in the trimethylation of H3K4 and H3K79, we 
hypothesized that there might exist a qualitative difference in the trimethylation status of H3K4 
at the HMR region and downstream loci through to the ADE2 gene in strains of WT, rpd3∆, and 
the double mutants, bre1∆rpd3∆ and bre2∆rpd3∆. 
        We have already shown that the silencing effect of rpd3Δ at HMR is abolished in both the 
double mutants of bre1Δrpd3Δ and bre2Δrpd3Δ. If BRE1 or BRE2 have a direct effect on the 
methylation status of the underlying chromatin as effectors, we hypothesize that there would be 
reduced enrichment of trimethylated H3K4 (H3K4me3) in the silenced regions downstream of 
the tRNA barrier element in rpd3Δ strains and higher enrichment of H3K4me3 at these same 
regions in both the WT and double mutant strains of bre1Δrpd3Δ and bre2Δrpd3Δ. We 
performed chromatin immunoprecipitation (ChIP) using an antibody specific for H3K4me3 to 
immunoprecipitate regions of HMR and downstream loci enriched in H3K4me3 (Figure 2.5).        
The PCR primer sets used to amplify enriched regions include four regions in and between the 
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two silencer sequences, E and I (A-D), the tRNA barrier element (E), and three regions in the 
inserted downstream ADE2 gene (F-H). 
 
 
 
 
         
 
As shown in Figure 2.5, there was no significant (or reproducible) difference in the enrichment 
of H3K4me3 across the HMR and downstream region in WT vs. rpd3Δ cells. In fact, qualitative 
enrichment levels appear to be almost identical in all regions assayed between the two strains, 
with regions B, D, and E (Intra-HMR, I silencer, and tRNA gene) possibly showing slightly less 
enrichment than the other sites in both strains (although Input Control for B and D also shows 
less enrichment). We also followed up these ChIP experiments by assaying the enrichment of 
Figure 2.5. ChIP (chromatin immunoprecipitation) of targeted H3K4me3 along the HMR 
and downstream loci in wild-type vs. rpd3Δ cells. Schematic representation of the HMR region 
with oligo primer sets labeled A through H at the regions where immunoprecipitated H3K4me3 
cross-linked to DNA was PCR amplified. Shown below the schematic are the qualitative 
enrichment levels of PCR-amplified regions A through H in WT and rpd3Δ strains tested. Also 
included is a no antibody control (No Ab) which shows levels of non-specific background 
enrichment and an input control for loaded DNA quantities. 
65 
 
H3K4me3 in the double mutants of bre1∆rpd3∆ (DDY 3790) and bre2∆rpd3∆ (DDY 3918) 
using the same PCR amplified regions comparing rpd3Δ and WT (data not shown). There was 
also no reproducible difference in the trimethylation status of the entire HMR region using the 
same primer sets A through H in both double mutants. Consistent with these null ChIP results 
was the lack of consistent levels of immunoprecipitated H3K4me3 protein from Western blot 
experiments in WT, rpd3∆, and both double mutant strains tested. 
        COS7 is a protein of undefined function but is a member of the DUP380 subfamily of 
conserved, often subtelomerically-encoded proteins; the authentic, non-tagged protein is detected 
in highly purified mitochondria in high-throughput studies (Spode, Maiwald et al. 2002). The 
COS7 gene was previously used by Kirmizis et al. (2007) as a positive control in ChIP assays for 
5’ enrichment of H3K4me3 levels (Kirmizis, Santos-Rosa et al. 2007). We employed the same 
strategy and unlike this published report, our results showed equilavent levels in enrichment of 
H3K4me3 at both the 5’ and 3’ ends of COS7 (whereas trimethylation enrichment is reported as 
progressively decreasing from the 5’ to the 3’ end of the ORF). These results, along with the 
acquisition of newer evidence on the mechanisms of silencing at telomeres involving the re-
distribution of Sir proteins, (Santos-Rosa, Bannister et al. 2004; Venkatasubrahmanyam, Hwang 
et al. 2007; Ehrentraut, Weber et al. 2010), have prompted us to refine both our model and 
hypothesis of the mechanism by which enhanced silencing occurs at HMR in rpd3Δ cells. Our 
adjusted hypothesis also reflects the role that BRE1 and BRE2 play in the establishment of 
extended silencing (methylation). 
DISCUSSION 
        Previous results in our laboratory showed an enhanced silencing effect at HMR in rpd3Δ 
strains, which bypassed the downstream tRNA barrier element. A novel bromodomain 
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containing gene, YTA7, was also shown to be required for restricting the propagation of silencing 
independent of the tRNA barrier element (Jambunathan, Martinez et al. 2005). These results 
implicate other factors can be involved in abolishing the spreading of heterochromatin such as 
other bromodomain-containing proteins, along with factors involved in the proper functioning of 
barriers. Alternatively, there are potential factors besides the ubiquitous Sir proteins involved in 
the establishment, propagation, and maintenance of the increased silencing effect at HM, 
telomeres, and ribosomal DNA loci in the rpd3Δ background. Using a genetic screen involving 
UV-mutated rpd3Δ yeast strains, our results identified two effectors of the rpd3Δ silencing effect 
that are essential for the extended spreading of heterochromatin which bypasses or spreads 
through the tRNA barrier element at HMRa. These two effectors were identified as BRE1 and 
BRE2. BRE1 encodes an E3 ubiquitin ligase for Rad6p and exists as a complex between the two, 
where the heterocomplex is recruited to promoter regions and is responsible for the 
ubiquitylation of H2BK123. This ubiquitylation of H2BK123 is required for the subsequent 
trimethylation of H3K4 by the COMPASS complex and trimethylation of H3K79 by Dot1p. 
Because of the direct methylation function of both these genes, it was of interest to analyze this 
histone modification status of the HMR region. 
        Although we took advantage of the inserted URA3 gene on chromosome VII-L near the 
telomere to assess silencing at telomeric ends, our main focus was to identify potential effectors 
of heterochromatic silencing at HMR, since the goal and the focus of our studies was to elucidate 
the mechanisms involved in the enhanced spread of silencing past the tRNA barrier element. 
Based on the limited amount of preliminary data generated from growth assays that depend on a 
marker gene at a telomere, there appears to be effects on silencing occurring at telomeres 
mediated by BRE1.  
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        Strains deleted for RPD3 not only exhibit enhanced silencing at HM loci, telomeres, and 
rDNA, but they also have a sporulation defect in homozygous diploid strains (rpd3Δ/rpd3Δ). To 
determine if BRE1 or BRE2 contributed to this defect, we attempted to sporulate the homozygous 
diploids rpd3Δbre1Δ/rpd3Δbre1Δ and rpd3Δbre2Δ/rpd3Δbre2Δ on carbon source-limiting 
nitrogen-rich nutrient media and observe if these double mutant strains would correct the 
sporulation defect that occurs in the homozygous rpd3Δ/rpd3 strains. Both diploid double 
mutants showed no change of function in the sporulation/meiosis defect in rpd3Δ strains. After 
3-4 days on nutrient limiting media at 30C and using light microscopy, we saw no formation of 
sporulated tetrads from the diploids on YPD media. Another phenotype of an rpd3Δ strain is its 
sensitivity to ethidium bromide during cell growth and mitosis. Neither of the double mutants 
showed a decrease in growth sensitivity to ethidium bromide (growth on ethidium bromide-
supplemented YPD was not enhanced in the double mutants) compared to WT.   
        The results we obtained in our ChIP assays were surprising since previous studies of the 
COS7 gene have shown that there are progressive differences in H3K4me3 enrichment between 
promoter and coding regions with a gradual decline of H3K4me3 levels from the 5’ to the 3’ end 
(Kirmizis, Santos-Rosa et al. 2007). Another gene, PPH3, encodes the catalytic subunit of an 
evolutionarily conserved protein phosphatase complex containing Psy2p and the regulatory 
subunit Psy4p. PPH3 is required for cisplatin resistance and is involved in the activation of 
Gln3p (Hoffmann, Jung et al. 1994). PPH3 is a constitutively active gene positively regulated by 
the trimethylation of H3K4 by Set1p and has been employed as a positive control in previous 
ChIP studies using antibodies specific for H3K4me3 (Santos-Rosa, Schneider et al. 2002). Our 
ChIP assays at the genomic locus of PPH3 also resulted in equivalent enrichments of H3K4me3 
contrary to previously reported results.  
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        These inconsistent and/or irreproducible ChIP results throughout the entire study shed doubt 
on the quality of the polyclonal H3K4me3 antibody (AbCam #ab8580). The antibody used was 
reportedly tested by the manufacturer with a blocking assay where the antibody detects a 17 kDa 
band on a Western blot which is completely blocked by the addition of histone H3K4me3 
peptide. Partial blocking was also observed with addition of histone H3K4me2 peptide 
(http://www.abcam.com/Histone-H3-tri-methyl-K4-antibody-ChIP-Grade-ab8580.html). The 
specificity of the antibody used in our assays was not tested by the manufacturer in vivo, and our 
results may reflect differences in binding of the antibody by short peptides versus the native 
histone H3 protein.  
        The elusive mechanism of enhanced silencing in rpd3Δ strains at HM, telomeres, and rDNA 
have perplexed researchers for over fifteen years. With the growing complexity of the ‘histone 
code’ hypothesis, many studies have tried to elucidate the mechanism of silencing by the pattern 
of histone modifications using genome-wide high-throughput ChIP-CHIP based assays. Research 
on chromatin has also delved into the degree of chromatin-associated proteins or other factors 
that directly bind to chromatin along with the specific modifications on particular amino acid 
residues on histone proteins. More recent studies have looked to how indirect effects can 
possibly play a role in the establishment or disruption of silencing heterochromatin. Our adjusted 
hypothesis includes the supposition of indirect effects on how BRE1 and BRE2 contribute to 
establishing the extended silencing in rpd3Δ strains. Chapter four of this dissertation will further 
expand on our modified hypothesis and concomitant strategy in future experimental design and 
execution, while at the same time taking into consideration the results of new studies, which 
report intriguing evidence of indirect mechanisms to these silencing effects.  
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Table 2.4. Strains of S. cerevisiae used in this study:  
Strain  Genotype 
DDY(Table 2.1.) MATα  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2   rpd3Δ::KanMX 
DDY 2  MATα/MATa  ade2/ADE2  his3/his3  leu2/leu2  LYS2/lys2Δ  trp1/trp1  ura3/ura3 
DDY 3  MATa   ADE2   his3-11   leu2-3,112   lys2Δ   trp1-1   ura3-1   ^GAL can1-100 
DDY 4  MATα  ADE2  his3-11   leu2-3,112   lys2Δ   trp1-1   ura3-1   ^GAL can1-100 
DDY 19  MATα his4 
DDY 20  MATa his4 
DDY 1671  MATα ADE2 his3 leu2 lys2Δ trp1 ura3 rpd3Δ::LEU2 
DDY 1677  MATa  ADE2 his3 leu2 lys2Δ trp1 ura3  rpd3Δ::LEU2 
DDY 3018  MATα ADE2 his3 leu2 lys2 trp1 ura3  rpd3Δ::KanMX  HMR wild type 
DDY 3136  MATα ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2    
DDY 3155  MATα ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2   rpd3Δ::KanMX 
DDY 3021  MATa ADE2 his3 leu2 lys2 trp1 ura3  rpd3Δ::KanMX   HMR wild type 
DDY 3133  MATα ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2   rpd3Δ::KanMX 
DDY 3160  MATα  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2    
DDY 3161  MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2    
DDY 3162  MATa  ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2   rpd3Δ::KanMX 
DDY 3408  MATα  ade2  his3  leu2   lys2   trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2   rpd3Δ::KanMX 
DDY 3690  MATα  ade2  his3  leu2 LYS2   trp1  ura3  HMR-tRNA+19-ADE2  BRF1:3X FLAG:KanMX sir4Δ::LEU2 
DDY 3761-3763 MATa  ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2  bre1Δ::LEU2 
DDY 3764-3766 MATa  ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2  gdh2Δ::LEU2 
DDY 3767-3769 MATa  ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2  rxt3Δ::LEU2 
DDY 3790 MATα ade2 his3 leu2 LYS2 trp1 ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2  rpd3Δ::Kan MX  bre1Δ::LEU2 
DDY 3825  MATα ade2 his3 leu2 lys2 trp1 ura3 bre2Δ::LEU2 
DDY 3846  MATa  ade2  his3  leu2  LYS2  trp1  ura3  VII-L-URA3-TEL   ppr1Δ::TRP1   HMR-ADE2  gat3Δ::LEU2    
DDY 3847  MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   bre2Δ::LEU2 
DDY 3848  MATα  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   bre2Δ::LEU2    
DDY 3854  MATa  ade2  his3  leu2  lys2  trp1  ura3  HMR-ADE2   bre2Δ::LEU2 
DDY 3855  MATα  ade2  his3  leu2  lys2  trp1  ura3  HMR-ADE2   bre2Δ::LEU2 
DDY 3878-3880 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   bre2Δ::LEU2   ppr1Δ::TRP1 
DDY 3881-3884 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   ppr1Δ::TRP1  bre1Δ 
DDY 3918 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2  ppr1Δ::TRP1  bre2Δ::LEU2  rpd3Δ::KanMX 
DDY 3970-3973 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2  ppr1Δ::TRP1  bre2Δ 
DDY 3984-3986 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   ppr1Δ::TRP1  bre1Δ 
DDY 3987-3989 MATa  ade2  his3  leu2  lys2  trp1  ura3  VII-L-URA3-TEL  HMR-ADE2   ppr1Δ::TRP1  bre2Δ 
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INTRODUCTION 
        The eukaryotic RNA polymerase III (Pol III) system is responsible for synthesizing transfer 
RNA molecules and other transcripts, which in yeast include the U6 spliceosomal RNA, the 7SL 
RNA, the 5S ribosomal RNA, the snr52 snoRNA, and the RNA component of RNaseP (Paule 
and White 2000; Geiduschek and Kassavetis 2001; Huang and Maraia 2001). Transcription by 
Pol III requires the activity of the multi-subunit transcription factor complex TFIIIC, which binds 
to conserved A-box and B-box Pol III promoter elements, and functions to overcome chromatin 
repression of Pol III transcription and to recruit the TFIIIB complex (Burnol, Margottin et al. 
1993; Kundu, Wang et al. 1999; Geiduschek and Kassavetis 2001). While Pol III and its 
transcription factors are thought to be dedicated to transcription of these specific genes, a 
growing body of evidence has shown that both partial and complete chromosomally bound Pol 
III complexes can have effects on RNA Polymerase II (Pol II) promoters (Donze and Kamakaka 
2001; Simms, Miller et al. 2004; Noma, Cam et al. 2006; Scott, White et al. 2007; Simms, Dugas 
et al. 2008). Chromatin bound Pol III complexes also mediate other extra-transcriptional 
functions including targeting Ty element integration (Chalker and Sandmeyer 1992; Kirchner, 
Connolly et al. 1995; Devine and Boeke 1996), blocking of replication fork progression 
(Deshpande and Newlon 1996), condensin and cohesin recruitment (Dubey and Gartenberg 
2007; Haeusler, Pratt-Hyatt et al. 2008), and direct inhibition of transcription from nearby Pol II 
promoters (Kinsey and Sandmeyer 1991; Hull, Erickson et al. 1994; Bolton and Boeke 2003; 
Simms, Miller et al. 2004). 
        Studies in both budding and fission yeast initially identified the presence of genome 
sequences that bind the TFIIIC complex, but not the other Pol III transcription factors TFIIIA, 
TFIIIB, or the Pol III enzymatic complex itself (Harismendy, Gendrel et al. 2003; Roberts, 
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Stewart et al. 2003; Moqtaderi and Struhl 2004; Noma, Cam et al. 2006). Recently, similar sites 
have been identified in human cells (Canella, Praz et al. 2010; Moqtaderi, Wang et al. 2010; 
Oler, Alla et al. 2010; Raha, Wang et al. 2010). These B-box containing sequences are referred 
to either as ETC (Extra TFIIIC) or TFIIIC-only sites in budding yeast, and COCs (Chromatin 
Organizing Clamps) in fission yeast (Roberts, Stewart et al. 2003; Moqtaderi and Struhl 2004; 
Noma, Cam et al. 2006). Particular TFIIIC binding sites have been shown to function as 
chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008), but the 
genome-wide function of the TFIIIC bound ETC sites remains unknown. 
        Interestingly, one ETC site in Saccharomyces cerevisiae, ETC6, lies within the promoter of 
the TFC6 gene, which encodes a subunit of the TFIIIC complex itself. We hypothesized that the 
Tfc6 protein, as part of the TFIIIC complex, might autoregulate its own promoter by binding to 
ETC6 and function as an insulator. Autoregulation of gene expression is critically important in 
all forms of life, from its role in the lysogen/lytic growth decision of bacteriophage λ (Ptashne 
2005), to having important roles in developmental and neuronal gene expression in metazoans 
(Crews and Pearson 2009; Hobert 2011). Our results identify the B-box within ETC6 as a 
functional regulatory element within the TFC6 promoter that mediates stringent autoregulation 
of the promoter; this regulation is sensitive to Tfc6 protein levels and binding of the TFIIIC 
complex. This appears to be the first demonstration of a core Pol III transcription factor complex 
directly regulating the transcription of a Pol II promoter, and this tight regulation of Tfc6p levels 
could be important in regulating global tRNA expression, which could have subsequent global 
effects on translational regulation. Our results also implicate a potential UAS immediately 
upstream of ETC6 that potentially binds an activating transcription factor which gives us clues to 
the mechanism of TFC6 gene activation/regulation and TFIIIC’s role as an insulator. 
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MATERIALS AND METHODS  
         5’RACE analysis was performed using the First Choice RLM-RACE kit (Ambion-Applied 
Biosystems #AM1700). Construction of the promoter mutants is described in the legend to 
Figure 3.1. Each mutant intergenic region was re-integrated into chromosome IV by 
transformation into strain DDY3453 (etc6Δ::URA3) and selection on 5-FOA media, and were 
verified by PCR of genomic DNA, and digestion of the PCR products with Drd I to verify the 
presence of the mutation. DDY3453 was created by standard yeast knockout techniques using 
oligonucleotides DDO-792 and 793 to amplify URA3 from plasmid pRS406 (Sikorski and Hieter 
1989). All oligonucleotide sequences are listed in Table 3.2. Northern blot analyses were 
performed as described in Chapter Two (Methods).  
        Plasmids expressing TFIIIC subunits Tfc1p, Tfc3p, and Tfc6p were constructed by PCR 
amplification of each gene plus approximately 500 base pairs upstream and downstream from 
yeast genomic DNA using the high fidelity Phusion DNA polymerase (New England Biolabs, F-
530S). Functional expression was verified by complementation of mutant strains. TFC4 was 
subcloned from a previously characterized plasmid PCF1 (kindly provided by Ian Willis). Each 
gene was cloned into the HIS3 marked pRS series of ARS-CEN and 2μ vectors (Sikorski and 
Hieter 1989; Kurdistani and Grunstein 2003). 
        Chromatin immunoprecipitation (ChIP) was performed as described in Chapter Two 
(Methods), using the TFC1-3X-FLAG allele crossed into the appropriate strains. Anti-FLAG 
monoclonal M2 was from Sigma (F1804), and anti-yeast TBP from Santa Cruz Biotechnology 
(sc-33736). Quantitation of ChIP signals was determined by radioactive PCR according to 
(Kurdistani and Grunstein 2003), except that samples were resolved on 1.2% agarose gels. ChIP 
signals were normalized to the background PCR signal generated using primers homologous to 
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the non-TFIIIC binding GAL1-10 intergenic region (oligos DDO1023 and 1024) to control for 
background and sample variation. All quantitative ChIP results were averaged from three 
independent determinations. 
        TFC6 promoter-URA3 ORF reporter strains were constructed by standard yeast 
recombination methods, using oligonucleotides DDO-1201 and DDO-1202 homologous to the 
ends of the URA3 open reading frame plus 50 bases immediately upstream and downstream of 
the TFC6 open reading frame to amplify the coding sequence of URA3. Ura+ recombinants 
expressing URA3 from the TFC6 promoter were slow growing on media lacking uracil (required 
4-5 days to appear) and were slightly temperature sensitive; therefore all colony growth 
experiments were performed at 25ºC. To compare colony sizes, tfc6Δ::URA3 cells were 
transformed with empty pRS vector (Sikorski and Hieter 1989; Christianson, Sikorski et al. 
1992) or HIS3 marked TFIIIC subunit expressing plasmids and plated on minimal media lacking 
histidine. His+ isolates were grown in liquid media lacking histidine and plated at ~50 
colonies/plate on media lacking histidine, and media lacking both histidine and uracil. Plates 
were incubated at 25ºC for three days (minus histidine) or five to six days (minus histidine and 
uracil) before photographing. Relative colony sizes from 30-50 colonies were measured and 
analyzed using ImageJ software (http://rsbweb.nih.gov/ij/). 
Table 3.1.  Plasmids used and/or generated in this study: 
Plasmid       Reference/Source 
pRS406 URA3 vector      (Sikorski and Hieter 1989) 
pRS413 ARS-CEN HIS3 vector      (Sikorski and Hieter 1989) 
pRS423 2μ HIS3 vector      (Christianson, Sikorski et al. 1992) 
pDD1098 TFC6-ESC2 intergenic region (~640 bp) in Bluescript SK+  (Simms, Dugas et al. 2008) 
pDD1179 TFC6 in pRS413, ARS-CEN HIS3     This study 
pDD1184 TFC6 promoter mutant #1      This study 
pDD1185 TFC6 promoter mutant #2      This study 
pDD1186 TFC6 promoter mutant #3      This study 
pDD1187 TFC6 promoter mutant #4      This study 
pDD1188 TFC6 promoter mutant #5      This study 
pDD1189 TFC6 promoter mutant #6      This study 
(Table 3.1 Continued) 
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pDD1190 TFC6 promoter mutant #7      This study 
pDD1197 TFC6 in pRS423, 2μ HIS3      This study 
pDD1226 TFC1 in pRS423, 2μ HIS3      This study 
pDD1228 TFC3 in pRS423, 2μ HIS3      This study 
pDD1234 ADH1 promoter-TFC6 in pRS413, ARS-CEN HIS3    This study                                      
pDD1244 TFC6-FLAG in pRS423, 2μ HIS3     This study 
pDD1245 TFC6-FLAG in pRS413, ARS-CEN HIS3     This study 
 
 
 
Table 3.2. Oligos used in this study: 
Oligo    Sequence 
TFC6 promoter mutagenesis – bases in red correspond to the Drd I site as described in the methods  
DDO-1135  CATTTCTTTTCTTATATGCTACAATGACCGGGTAGTCCTTCTGTAAGGAAATAGAAGG  TFC6 PROMOTER MUTANT #1 top 
DDO-1136  CCTTCTATTTCCTTACAGAAGGACTACCCGGTCATTGTAGCATATAAGAAAAGAAATG  TFC6 PROMOTER MUTANT #1 bottom 
DDO-1137  GCTACAATAAAATTTGCTGTCGACGTGCCTGTCATAGAAGGGATTCAGTATCACC  TFC6 PROMOTER MUTANT #2 top 
DDO-1138  GGTGATACTGAATCCCTTCTATGACAGGCACGTCGACAGCAAATTTTATTGTAGC  TFC6 PROMOTER MUTANT #2 bottom 
DDO-1139  GTAAGGAAATAGAAGGGATTCAGGACACAAATGTCAGCTGCGGTTCGAAAACCCTAC  TFC6 PROMOTER MUTANT #3 top 
DDO-1140  GTAGGGTTTTCGAACCGCAGCTGACATTTGTGTCCTGAATCCCTTCTATTTCCTTAC  TFC6 PROMOTER MUTANT #3 bottom 
DDO-1141  GGATTCAGTATCACCCGGAAGACGTATTGGTCAAAACCCTACGTTGCAAAAGAAG  TFC6 PROMOTER MUTANT #4 top 
DDO-1142  CTTCTTTTGCAACGTAGGGTTTTGACCAATACGTCTTCCGGGTGATACTGAATCC  TFC6 PROMOTER MUTANT #4 bottom 
DDO-1143  CACCCGGAAAGCTGCGGTTCGGACCAAAGCGTCTGCAAAAGAAGATAAACAACATTC  TFC6 PROMOTER MUTANT #5 top 
DDO-1144  GAATGTTGTTTATCTTCTTTTGCAGACGCTTTGGTCCGAACCGCAGCTTTCCGGGTG  TFC6 PROMOTER MUTANT #5 bottom 
DDO-1145  CGGTTCGAAAACCCTACGTGACCCCCTCGTCTAAACAACATTCCATTTTTTGTTCG  TFC6 PROMOTER MUTANT #6 top 
DDO-1146  CGAACAAAAAATGGAATGTTGTTTAGACGAGGGGGTCACGTAGGGTTTTCGAACCG  TFC6 PROMOTER MUTANT #6 bottom 
DDO-1147  GCAAAAGAAGATAAACAACATTCCGACTTTTGTGTCAGAAAGCCTGGATGAGTTG  TFC6 PROMOTER MUTANT #7 top 
DDO-1148  CAACTCATCCAGGCTTTCTGACACAAAAGTCGGAATGTTGTTTATCTTCTTTTGC  TFC6 PROMOTER MUTANT #7 bottom 
Chromatin IP 
DDO-305  CGTGCCGGTGAAACATATATGTCT      Chromosome XVI tF(GAA)P2 ChIP top 
DDO-306  CAAGTTCAAGAACCAACTTTCCGC      Chromosome XVI tF(GAA)P2 ChIP bottom 
DDO-307  GCACTAGTTGATTCTTGTTCCAACAG      Chromosome VII tK(CUU)G1 ChIP top 
DDO-308  CCGTTTTTCCCCAGAGCACTTTTA      Chromosome VII tK(CUU)G1 ChIP bottom 
DDO-705  ATTATTACACGTATCGCAATGG       ETC6 ChIP top 
DDO-1093  CTTCTGGAATCACCGGTCATC       ETC6 ChIP bottom 
DDO-1023  CCATATACATATCCATATCTAATC      GAL LOCUS ChIP top 
DDO-1024  ATAACCATAAAAGCTAGTATTGTAG      GAL LOCUS ChIP bottom 
DDO-1215  GCCATTCTCTTATCTTCCAAG       ETC4 ChIP top 
DDO-698  AAGTAAGGTTTGCATATGCGG       ETC4 ChIP bottom 
DDO-1343  GTCTTAGTTTGATTGAGCGACAAG      ETC5/RNA170 ChIP top 
DDO-1344  AAACAAGGGTTGTGGAGTATGC       ETC5/RNA170 ChIP bottom 
DDO-1345  TAGCAGTTTATGTACGCATTTTAAAAGC      ZOD1 ChIP top 
DDO-1346  TGCTGTCTTATTCCCTAGTGTC       ZOD1 ChIP bottom 
DDO-1402  TACGACATCAAAGTCGCCGAG       Chromosome XII tR(CCG)L CHIP TOP 
DDO-1403  ATTGACAGCCCTTACGCGAAG       Chromosome XII tR(CCG)L CHIP bottom 
Knockout and insertion – bases in green correspond to the pRS416 plasmid sequence adjacent 
to URA3. Bases in red correspond to the start and end of the URA3 open reading frame. 
DDO-792 CAACTCATCCAGGCTTTCTCGAACAAAAAATGGAATGTTGTTTATCTTCTTTTGCAGATTGTACTGAGAGTG 
ETC6 delete URA3 KO TOP 
DDO-793 ATTTGCTGTCTTCTGTAAGGAAATAGAAGGGATTCAGTATCACCCGGAAAGCTCTCCTTACGCATCTGTGCGG 
ETC6 delete URA3 KO BOTTOM 
DDO-1201 CTCTAACTTGCTCCATTGCGATACGTGTAATAATATATTAAGTTGTGGCGATGTCGAAAGCTACATATAAG 
TFC6 del URA3 ORF top 
DDO-1202 GTCAACAATAGTTCAATGTCACAAATTGTATTTATTACGTAAAGTCCATCTTAGTTTTGCTGGCCGCATC 
TFC6 del URA3 ORF bottom 
 
RESULTS 
Inhibition of TFIIIC Binding to ETC6 Results in Increased TFC6 Transcript Levels.  
        We used a combined transcript mapping, bioinformatic and mutational approach to identify 
the potential promoter elements upstream of TFC6. 5’-RACE analysis was performed to map 
transcriptional start sites, which were identified at bases minus 46, 96, 98, 104, and 110 from the 
annotated TFC6 translational start site (Figure 3.1).  
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Figure 3.1. Comparison of the TFC6 promoter region among budding yeast species. 
Sequences were aligned using Clustal software available through the Saccharomyces Genome 
Database website. Shaded boxes covering regions of highest homology were designated as sites 
1-7, and were mutated as described below; mutagenic oligonucleotides are listed in Table 3.2. 
Transcription start sites marked in red were determined by 5’RACE analysis. The numbers above 
each arrow refer to the location of the start site relative to the start codon (Met), and the numbers 
in parentheses are the number of independent 5’RACE clones obtained for that start site. The 
region of the ETC6 B-box is marked by the green shading. 
Promoter mutants were constructed by site-directed mutagenesis of plasmid pDD1098 which 
contains the TFC6-ESC2 intergenic region (from Saccharomyces Genome Database chromosome 
IV coordinates 1198718 to 1199357, www.yeastgenome.org/, as of 20 October 2010) cloned into 
Bluescript SK+. Each mutant had a 12 base pair region replaced with a Drd I restriction enzyme 
site (Quik-Change kit, Stratagene), which allowed scrambling of 10-12 base pairs within each 
region, and initial restriction digest screening of mutants, which were verified by DNA 
sequencing. 
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        Mapping of the start sites allowed us to focus on the upstream region to identify promoter 
elements. Comparison of the TFC6 promoter regions from five budding yeast species revealed 
regions of high conservation in addition to the ETC6 site B-box sequence. Regions containing 
six or more bases common to all five species over a twelve base stretch were designated as 
promoter boxes 1-7, as shown schematically in Figure 3.2A and at sequence level detail in 
Figure 3.1. These 12-base pair boxes were mutated on plasmids, re-integrated into the yeast 
genome, and Northern blot analysis for TFC6 mRNA was performed for each mutant. 
        The results in Figure 3.2B show that the major effects were seen clustered across promoter 
mutants 3, 4, and 5. Mutant 3 results in a significant decrease in TFC6 mRNA, and this mutant is 
compromised for growth due to limiting TFC6 expression, as complementation with a TFC6 
plasmid restores normal growth (Figure 3.3). Mutants 4 and 5, which both span the ETC6 site, 
show a 2-fold increase in TFC6 mRNA levels, which is consistent with our previous results 
mutating this site (Simms, Dugas et al. 2008). These results are also consistent with mutant 3 
affecting a transcription factor binding site, and with the ETC6 site B-box being involved in 
negative regulation of the TFC6 promoter.  
        To further test the hypothesis that TFIIIC binding to ETC6 is involved in TFC6 auto-
regulation, we performed TFC6 Northern blots on strains containing conditional mutations of the 
RNA polymerase III machinery. The mutant tfc3-G349E is a temperature sensitive allele of a 
TFIIIC component that reduces binding affinity (measured in vitro) of the TFIIIC complex for 
tDNAs (Lefebvre, Ruth et al. 1994). Mutations brf1 II-9 and II-6 are impaired in Brf1p 
interaction with TBP (Andrau, Sentenac et al. 1999); rpc31-236 is defective in Pol III initiation 
(Thuillier, Stettler et al. 1995); and rpc160-112 is defective in elongation (Dieci, Hermann-Le 
Denmat et al. 1995).  
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Figure 3.2. Characterization of the S. cerevisiae TFC6 promoter suggests autoregulation by 
the TFIIIC complex. A) Transcriptional start sites upstream of TFC6 were mapped by 5’- RACE 
analysis, and are detailed in Figure 3.1. TFC6 promoter regions of highest homology among five 
budding yeast species are designated promoter boxes 1-7, also detailed in Figure 3.1. B) Mutant 
promoters were re-integrated into the yeast chromosome, and relative TFC6 mRNA levels 
determined by Northern blotting. Expression was determined from three independently isolated 
strains for each mutation; one each is shown here. C) Temperature sensitive mutation in TFC3, 
but not other Pol III mutations result in increased TFC6 transcript levels. Strains containing 
mutant alleles of TFIIIC, TFIIIB, and Pol III components were grown at permissive temperature 
(30C), then pulsed for one hour at the non-permissive temperature (37C) before RNA extraction 
and Northern analysis. 
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        The results in Figure 3.2C demonstrate that only the tfc3-G349E mutant contained increased 
TFC6 transcript levels. This is consistent with direct TFIIIC mediated regulation of TFC6 
Figure 3.3. TFC6 promoter mutant #3 exhibits a slow growth phenotype due to insufficient 
TFC6 expression. Wild type (DDY3630) and promoter mutant #3 (DDY4301) strains were 
transformed with either HIS3 vector (pRS413) or the same vector containing the TFC6 gene 
(pDD1179), and streaked onto minimal media lacking histidine. The slow growth phenotype of 
strain DDY4301 is complemented by the TFC6 expressing plasmid. Identical complementation 
results were obtained using two independent promoter mutant #3 isolates, and also in strain 
DDY4114 (described in Simms et al, 2008), which has the ETC6 site and the upstream region 
deleted. 
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transcription, and not a result of reduced Pol III activity, as the other mutations that globally 
impair Pol III transcription had little effect on TFC6 mRNA levels. 
Inverse Correlation of TFIIIC Association at ETC6 and TFC6 Transcript Levels.  
        To confirm that the mutant etc6 and tfc3 strains were indeed defective for in vivo binding of 
TFIIIC to ETC6, we performed chromatin immunoprecipitation (ChIP) against a carboxy-
terminal 3XFLAG-epitope tagged Tfc1p subunit (Figure 3.4) in both tfc3-G349E and etc6 B-box 
mutant strains. The B-box mutation changes a cytosine residue conserved in all TFIIIC binding 
sites to a guanine, and is known to inhibit TFIIIC binding in vitro (Newman, Ogden et al. 1983). 
The results shown in Figure 3.4A illustrate that both mutations lead to a loss of TFIIIC 
association with the TFC6 promoter in vivo, and reduced binding correlates with the relative 
increase in TFC6 transcript levels in the same mutants (Figure 3.4B). 
Over-Expression of TFC6 Inhibits Expression From Its Own Promoter.  
        If Tfc6 protein levels are directly autoregulating its own promoter, then overexpression of 
TFC6 from an episomal plasmid was predicted to reduce transcription from the endogenous 
chromosomal promoter. In order to test this hypothesis, we created diploid yeast strains that have 
the URA3 open reading frame precisely replacing one chromosomal copy of the TFC6 open 
reading frame (Figure 3.5A). These strains allowed us to assess the level of TFC6 promoter 
activity independent of episomal expression by assessing growth on media lacking uracil. TFC6 
was overexpressed in strain DDY4520, both from its own promoter on a high-copy plasmid 
containing the entire TFC6 gene, or from the ADH1 promoter on a low copy plasmid. Increased 
TFC6 expression has no effect on growth of this strain on media lacking only histidine compared 
to cells transformed with the HIS3 vector alone (Figure 3.5B), showing that increased Tfc6p 
levels alone do not inhibit growth.  
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Figure 3.4. TFIIIC binding to ETC6 is inversely correlated to TFC6 mRNA levels. A) Strains 
containing 3X-FLAG-epitope tagged TFC1 and either tfc3-G349E or etc6 B-box mutant alleles 
were constructed, chromatin extracts prepared for immunoprecipitation and relative TFIIIC 
association at the TFC6 promoter determined. B) Reduction of TFIIIC binding by either mutation 
is correlated to increased TFC6 mRNA levels. 
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However, when the same cells were plated on minimal media lacking both histidine and uracil, 
the average colony sizes formed by cells containing either the high-copy or ADH1-promoter 
plasmid were consistently 65-70% of controls containing the empty vector. This effect is dose 
dependent, as expression of TFC6 from its own promoter on a lower copy ARS-CEN plasmid 
reduces average colony size to only 89% of controls (Figure 3.6 A & B). ChIP against TFC1-
3XFLAG showed that overexpression of TFC6 resulted in increased association of TFIIIC at 
ETC6 (Figure 3.5C), as the amount of TFC6 promoter DNA immunoprecipitated was ~1.7 times 
the vector control. This correlated with a decrease in TATA binding protein (TBP) association at 
Figure 3.5. Overexpression of Tfc6p down-regulates gene expression driven by the TFC6 
promoter, and increases the association of the TFIIIC complex to ETC6. A) Diploid strain 
DDY4520 was constructed to contain the URA3 open reading frame (ORF) integrated in place of 
the TFC6 ORF on one copy of chromosome IV to test the effects of episomal TFC6 
overexpression. B) Vector controls, 2μ HIS3 TFC6, or ARS-CEN HIS3 ADH1- promoter-TFC6 
plasmid transformants were plated on media lacking histidine or both histidine and uracil, and 
colony sizes were measured after three days (minus histidine) or five days (minus histidine minus 
uracil) at 25C. C) ChIP of TFC1-3X-FLAG strains transformed with vector or ADH1 promoter-
TFC6 plasmid show increased Tfc1p association, and decreased TBP at ETC6 when TFC6 is 
overexpressed. Quantitative results were averaged from three separate determinations. 
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the TFC6 promoter, as the anti-TBP ChIP signal was only ~70% compared to the vector control 
(Figure 3.5C). These results show that overexpression of TFC6 increases the degree of TFIIIC 
association with ETC6, and reduces expression from its own promoter, presumably due to 
increased stability of TFIIIC binding to the ETC6 site, leading to reduced TBP association. 
 
 
 
 
 
 
 
 
 
Auto-Regulation of TFC6 is ETC6 Site B-Box Dependent and Tfc6p Specific.  
        If increased binding of TFIIIC to ETC6 is indeed responsible for reduced growth on media 
lacking uracil, we predicted that a strain with URA3 driven by a TFC6 promoter containing the 
defective B-box within ETC6 would be insensitive to overexpressed TFC6 when grown on 
media lacking uracil.  
Figure 3.6. Tfc6p inhibition of Its own promoter is dose dependent. A) Strain DDY4403 
containing the TFC6 promoter driving URA3 was transformed with empty HIS3 vector, low 
copy ARS-CEN-TFC6 plasmid, or high copy 2μ-TFC6 plasmid. Platings and colony size 
determinations were as in Fig. 3.5 and as described in the methods. B) Bar graph represents the 
measurement of at least 30 colonies from three separate images. C) Western blot analysis to 
estimate the relative level of overexpression of TFC6. The same plasmids used in A and B were 
modified to contain the identical triple FLAG epitope that is integrated as a single copy in the 
haploid strain DDY4107 (pDD1244 = 2μ TFC6- 3XFLAG, pDD1245 = ARS-CEN TFC6-
3XFLAG). DDY4107 was then transformed with either empty HIS3 vector (pRS413) to measure 
normal Tfc6p levels, or each of the TFC6-FLAG plasmids. Total protein extracts from each 
strain were prepared and equal protein amounts were immunoprecipitated with anti-FLAG M2 
monoclonal antibody (Sigma), and the concentrated immunoprecipitates were analyzed by 
Western blotting using the same antibody. Relative amounts were assessed by scanning the blot 
on a Pharmacia Typhoon 8600 Phosphorimager on the chemiluminescent setting, and using 
ImageQuant software to measure the relative signals. 
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Figure 3.7. Downregulation of the TFC6 promoter by Tfc6p requires the ETC6 B-box and is 
specific to TFC6 overexpression. A) Strain DDY4521 was constructed to contain a mutant B-
box linked in cis- to the TFC6 promoter driving URA3. TFC6 was overexpressed as in Fig. 3.6., 
and was unable to downregulate the TFC6 promoter containing the mutant B-box, as indicated by 
no change in colony sizes. B) Overexpression of other TFIIIC subunits in DDY4403. High-copy 
2µ plasmids encoding each gene driven by its native promoter were transformed into the URA3 
reporter strain and plated on minimal media lacking histidine and uracil, and colony sizes relative 
to the vector control were determined as in Fig. 3.6. 
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Strain DDY4521 is identical to DDY4520 except for the presence of the cytosine to guanine 
mutation in the ETC6 B-box upstream of the URA3 marker. The results in Figure 3.7A confirm 
that the inhibition is mediated through the ETC site, as when TFC6 is overexpressed in the strain 
containing the mutant B-box, no reduction of colony size is observed on media lacking uracil. 
        We next asked if overexpression of other TFIIIC subunits would affect URA3 expression 
from the TFC6 promoter. Large-scale proteomic studies of yeast protein expression have 
estimated the number of protein molecules per yeast cell (Ghaemmaghami, Huh et al. 2003), and 
the results suggest that Tfc3p, Tfc4p, and Tfc6p are the most limiting components of the TFIIIC 
complex. Tfc1p appears to be present in large excess, and Tfc7p and Tfc8p are at intermediate 
levels. Indeed, this apparent excess of at least Tfc1p and Tfc7p was determined to exist as a 
chromatographically separable sub-complex in yeast extracts (Manaud, Arrebola et al. 1998). We 
confirmed that Tfc6p is limiting relative to Tfc1p, as Western blots of protein extracts from 
strains containing the identical triple FLAG epitope on each gene show a large relative excess of 
Tfc1p expression compared to Tfc6p (Figure 3.8.). We also determined by Western blotting that 
Tfc1p levels are not significantly affected by the tfc3-G349E temperature sensitive mutation used 
in this study (Figure 3.9.). These endogenous ratios suggest that overexpression of other limiting 
subunits might also increase the level of TFIIIC complex binding to ETC6 and reduce TFC6 
promoter activity, while overexpression of TFC1 should have no effect since it is already largely 
in excess. 2µ plasmids containing TFC1, TFC3, TFC4, and TFC6 were separately transformed 
into strain DDY4403 (TFC6 promoter-URA3, similar to DDY4520, but in the S288C 
background) and plated on media lacking both histidine and uracil. Colony sizes were 
determined at six days of growth, and the results are shown in Figure 3.7B. As expected, over-
expression of TFC1 had no effect on cell growth, nor did overexpression of TFC4. 
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Figure 3.8. Western blot analysis of yeast strains containing identical carboxy-terminal 
triple-FLAG epitope tags on TFC1 (DDY4381), TFC6 (DDY4107), or BRF1 (DDY844). 
Total protein extracts from each strain were prepared and equal protein amounts were 
immunoprecipitated with anti-FLAG M2 monoclonal antibody (Sigma), and the concentrated 
immunoprecipitates were analyzed by Western blotting using the same antibody. Tfc6 protein 
levels are limiting compared to Tfc1p and Brf1p levels. 
 
Figure 3.9. Tfc1p levels are not significantly affected by the tfc3-G349E temperature 
sensitive mutation. Whole cell extracts from TFC1-3XFLAG strains were prepared and 
equivalent protein amounts were immunoprecipitated with anti-FLAG antibody. The 
immunoprecipitates were subjected to Western blot analysis with anti-FLAG primary antibody. 
No significant difference was seen in the wild type versus tfc3-G349E mutant. 
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Expression of TFC3 appeared to inhibit growth slightly, but not as much as TFC6. These results 
demonstrate that the TFC6 promoter is preferentially sensitive to increased levels of its cognate 
gene product. 
Overexpression of TFC6 Results in Elevated TFIIIC Association at Multiple Loci.  
 
 
 
 
DISCUSSION 
        Since TFIIIC binding at ETC6 was increased upon overexpression of Tfc6p, we tested other 
B-box containing loci by ChIP for enrichment of the TFIIIC complex. The results in Figure 3.10 
demonstrate that all loci tested, which included three tDNAs, the ZOD1/UFO1 locus, and ETC4 
Figure 3.10. Overexpression of TFC6 increases TFIIIC association at multiple genomic loci. 
Strain DDY4381 (TFC1-3XFLAG) was transformed with either empty vector or pDD1234 
(ADH1 promoter-TFC6) to overexpress Tfc6p. Binding of TFIIIC was assessed at several B-box 
sites by ChIP using anti-FLAG antibody, each of which showed increased enrichment when 
Tfc6p was overexpressed. As in Figure 3.5, determinations were performed in triplicate, 
normalized to the GAL locus signal, and one pair of lanes is shown for each locus. 
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and ETC5, an increase in TFIIIC association was observed upon episomal expression of TFC6. 
The magnitude of this increase varied from 1.2-fold to over 2-fold. Despite this seemingly 
general increase in TFIIIC binding, we have not yet identified any tDNAs or other loci that show 
altered levels of Pol III transcription (see discussion). 
DISCUSSION 
        Although Pol III is dedicated to the transcription of tDNAs and a handful of other RNAs, 
genome wide ChIP studies in yeast have demonstrated the presence of the transcription factor 
complex TFIIIC at chromosomal locations not associated with the Pol III complex (Harismendy, 
Gendrel et al. 2003; Roberts, Stewart et al. 2003; Moqtaderi and Struhl 2004; Noma, Cam et al. 
2006). Recently, similar studies using human cells and high-throughput sequencing detection 
(ChIP-Seq) have also demonstrated the presence of such sites beyond yeast (Canella, Praz et al. 
2010; Moqtaderi, Wang et al. 2010; Oler, Alla et al. 2010; Raha, Wang et al. 2010). These loci 
have been referred to as ETC (extra TFIIIC) sites, COC (chromatin organizing clamps), or TFIIIC-
only sites, and have been shown to affect expression of neighboring Pol II genes by acting as 
chromatin boundary elements (Noma, Cam et al. 2006; Simms, Dugas et al. 2008). This study set 
out to further characterize the role of the TFIIIC binding site ETC6 in S. cerevisiae, which lies in 
the promoter of the TFC6 gene encoding a subunit of the TFIIIC complex itself. The location of 
this site was noted by Moqtaderi and Struhl in their study characterizing ETC sites (Moqtaderi 
and Struhl 2004), and they suggested the possibility that TFIIIC might regulate this promoter.  
        Our results confirm their speculation, as we show that ETC6 is a functional promoter 
element of the TFC6 gene that mediates autoregulation of TFC6 expression in response to Tfc6 
protein levels. We show that inhibition of TFIIIC binding to ETC6 results in increased TFC6 
transcript levels, while overexpression of Tfc6p increases association of the TFIIIC complex at 
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ETC6 and inhibits expression from the TFC6 promoter. These results suggest that Pol II 
transcription of TFC6 is sensitive to the level of its own protein product, a product that is part of 
what was previously thought to be a dedicated core Pol III transcription factor. While such 
crosstalk between Pol II transcription factors and Pol III promoters has been described for the 
Octamer binding proteins and the SNAPc complex in mammalian systems (Schramm and 
Hernandez 2002), they appear to be general Pol II transcription factors that act on a limited 
subset of Pol III promoters. Therefore, this does appear to be the first demonstration of a core Pol 
III factor regulating Pol II transcription.  
        The results presented here also begs the question of how does the TFIIIC complex inhibit 
expression from its own promoter. Data in Figure 3.5 show reduction in TBP association at the 
TFC6 promoter when TFC6 is episomally overexpressed; while this may be due to direct 
inhibition of TBP binding, this reduction might also be a consequence of other mechanisms. We 
previously suggested (Simms, Dugas et al. 2008) that inhibition may occur via an insulator-like 
mechanism, with bound TFIIIC inhibiting upstream transcription factors from recruiting a 
productive pre-initiation complex at the transcription start site. However, since the key TFC6 
promoter element (mutant site #3) is immediately upstream of the ETC6 B-box, we also consider 
that TFIIIC and the putative transcription factor may be in competition for binding to the same 
region of DNA. 
        While much work has been done on the global control of Pol III transcription by the Maf1 
mediated pathway (Willis and Moir 2007; Ciesla and Boguta 2008; Goodfellow, Graham et al. 
2008), few studies have looked at the role of the regulation of expression of the Pol III 
transcription factors themselves. In yeast, over-expression of TFIIIB70 (Brf1p) elevates expression 
of promoter mutant tDNAs (Sethy-Coraci, Moir et al. 1998). In mammalian cells, overexpression 
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of Brf1 stimulates Pol III transcription, while shRNA inhibition of Brf1 expression reduces 
oncogenic transformation and tumor formation in a mouse model (Johnson, Dubeau et al. 2008; 
Marshall, Kenneth et al. 2008). These results indicate that levels of the Pol III transcription 
factors can have critical roles in regulating Pol III transcription and cell proliferation. 
        Autoregulatory circuits have been identified as key components controlling gene 
expression, and have evolved in organisms from bacteriophage to humans (Crews and Pearson 
2009). Bacteriophage λ uses its CI repressor protein to both positively regulate its own 
expression, and then negatively regulate itself when the cellular concentration of the protein 
reaches proper levels, a key circuit in maintaining the inducible lysogenic state (Ptashne 2005). 
Neuronal terminal differentiation genes in C. elegans are controlled by autoregulated terminal 
selector transcription factors, and disruption of this process can lead to defective neuron function 
(Hobert 2011); many other instances of autoregulation could be cited (Crews and Pearson 2009). 
Given that, the results presented here suggest that in yeast there exists a tight regulation of TFC6 
expression that maintains its protein product as a limiting component of the TFIIIC complex. This 
fact raises the question as to why do yeast need to maintain such a stringent control of Tfc6p 
expression, and therefore TFIIIC activity. Since we observe that overexpression of Tfc6p 
differentially increases the Tfc1p ChIP signal at several loci (Figure 3.10), we speculate that 
altered Tfc6p levels might differentially regulate TFIIIC occupancy genome-wide, and possibly 
differentially affect expression levels of tRNAs and other Pol III transcripts. Recent studies have 
shown that slowly translated rare/sub-optimum codons play a role in fine-tuning translational 
regulation and protein stability and activity (Crombie, Boyle et al. 1994; Zalucki and Jennings 
2007; Zhang, Hubalewska et al. 2009; Tuller, Carmi et al. 2010; Zhang, Saha et al. 2010), 
therefore altered Tfc6p levels might differentially affect the production of tRNAs decoding these 
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regulatory codons, potentially having global effects on translational regulation. Although we 
have not yet detected any differences in Pol III transcription upon overexpression of Tfc6p (from 
a limited set of Pol III transcribed genes tested), a genome-wide analysis may reveal particular 
tDNAs whose expression is altered. Since many tDNAs are present in multiple copies in the 
yeast genome, such differences may only be revealed by tagging of individual loci to distinguish 
altered expression levels. 
        The work presented here is significant in that it appears to be the first demonstration of a 
core Pol III transcription factor that can directly regulate transcription from a Pol II promoter, 
that this stringent regulation could potentially be important in global gene expression, and adds 
another potential avenue of crosstalk among the different RNA polymerase systems (Conesa, 
Ruotolo et al. 2005). Additionally, since ETC-like sites have now been confirmed in human cells, 
the role of the TFIIIC complex in genome organization and global control of gene expression may 
be more prevalent than previously realized. 
Table 3.3. Strains of S. cerevisiae used in this study: 
Strain  Genotype                  Created 
DDY3   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1      Donze Lab 
DDY232   MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc31-236 hmrΔ     Donze Lab 
DDY237   MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 tfc3-G349E hmrΔ     Donze Lab 
DDY246   MATα ade2-1 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc160-Δ1::HIS3 p-rpc160-112    Donze Lab 
DDY247   MATa ade2-1 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 rpc160-Δ1::HIS3 p-rpc160-112    Donze Lab 
DDY261   MATα ADE2 his-3-11 leu2-3,112 LYS2 trp1-1 ura3-1 tfc3-G349E hmrΔΙ     Donze Lab 
DDY269   MATα ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 rpc31-236 hmrΔΙ     Donze Lab 
DDY416   MATa ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 brf1Δ::HIS3 p-brf1 II.9 hmrΔ    Donze Lab 
DDY420   MATα ADE2 his-3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 brf1Δ::HIS3 p-brf1 II.6 hmrΔ    Donze Lab 
DDY844   MATα ADE2 his4-519 leu2-3,112 LYS2 trp1-1 ura3-52 BRF1-3XFLAG-KanMX    Donze Lab 
DDY3453   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 etc6Δ::URA3     Donze Lab 
DDY4107   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 TFC6:3XFLAG:KanMX    Donze Lab 
DDY4274   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #1     This Study 
DDY4297   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #2    This Study 
DDY4300   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #3     This Study 
DDY4304   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #4     This Study 
DDY4306   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #5     This Study 
DDY4309   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #6     This Study 
DDY4312   MATa ADE2 his3-11 leu2-3,112 lys2Δ trp1-1 ura3-1 tfc6 promoter mutant #7     This Study 
DDY4077   MATa ADE2 his3-11 leu2-3, 112 LYS2 trp1-1 ura3-1 etc6 boxB TFC1-3XFLAG::KanMX   This Study 
DDY4376   MATa ADE2 his3-11 leu2-3, 112 lys2Δ trp1-1 ura3-1 tfc3-G349E TFC1-3XFLAG::KanMX   This Study 
DDY4381   MATα ADE2 his3-11 leu2-3, 112 lys2Δ trp1-1 ura3-1 TFC1-3XFLAG::KanMX    This Study 
 
 
(Table 3.3 Continued) 
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DDY4403   MATα/MATa ADE2/ADE2 his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met15Δ0/MET15 TRP1/TRP1  This Study 
ura3Δ0/ura3Δ0 TFC6/tfc6Δ::URA3 
DDY4520   MATα/MATa ade2-1/ADE2 his3-11/his3-11 leu2-3,112/leu2-3, 112 LYS2/lys2Δ trp1-1/trp1-1   This Study 
ura3-1/ura3-1 TFC6/tfc6Δ::URA3 
DDY4521   MATα/MATa ade2-1/ADE2 his3-11/his3-11 leu2-3,112/leu2-3, 112 LYS2/lys2Δ trp1-1/trp1-1   This Study 
ura3-1/ura3-1 TFC6/etc6 b-box-tfc6Δ::URA3 
 
All strains are isogenic to S. cerevisiae W-303 except for DDY4403, which is in the S288C background (BY4743 parent). 
Most experiments were confirmed with at least three independent isolates, only those isolates depicted in the figures are 
listed. Strains 4403, 4520, and 4521 contain the URA3 open reading frame expressed from the TFC6 promoter as described 
in the text and methods. 
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        Knowledge of the regulation of eukaryotic gene expression is expanding exponentially with 
the advent of genomic sequencing, particularly in Saccharomyces cerevisiae, the first eukaryotic 
organism in which the entire genomic sequence has been determined (Goffeau, Barrell et al. 
1996). Now a vast amount of genomic data is available for the approximately 6000 open reading 
frames in this simple budding yeast (Oliver 1996). A large body of research has focused on the 
three different eukaryotic RNA polymerases, the different types of promoters they utilize, and 
the additional regulatory genomic elements involved in transcriptional regulation. These studies 
include the effects on transcription by chromatin domains, along with their associated cis-
elements and trans-factors.  
        The cellular processes of transcription, replication, recombination, and repair all have to 
occur within the environment of chromatin and the particular hetero- or euchromatic state of the 
underlying domain. Regions of these different states of chromatin domains not only influence the 
topological characteristics of chromatin, but also the numerous mechanisms of activation and 
repression of certain genes at particular points in the cell cycle and developmental stages during 
metazoan development. A simple example of a well-studied mechanism of cellular 
differentiation (or cell fate) is the haploid mating type stability in S. cerevisiae where the cell 
mating type, a or α, is dependent on the silencing of the cryptic mating loci, HMR and HML. 
Loss of silencing at these HM loci can result in the cell taking on the characteristics of a non-
mating diploid.   
        Eukaryotic genomes are typically organized into domains containing individual genes or 
gene clusters that have distinct patterns of expression. Boundary elements, consisting of barriers 
and insulators, are specific sequences in the genome along with their associated DNA-binding 
proteins that inhibit the spread of heterochromatin into transcriptionally active euchromatic 
102 
 
regions and block the ectopic activation of genes from distal enhancers, respectively. Both 
elements are critical for the proper transcriptomal expression of the eukaryotic genome. Studying 
these elements in yeast enables us to acquire information on how the genome is organized and 
how the cell takes on a certain characteristic that differentiates it from another cell. This 
dissertation has focused on the study of the functional mechanisms of boundary elements, 
barriers and insulators, in their natural context.  
        Two main models have been proposed to explain how silenced domains are restricted from 
spreading by barrier elements. The nuclear organization model posits that barrier elements tether 
chromatin to nuclear superstructures to form topologically distinct domains, and this tethering 
prevents the spread of silenced chromatin. The chromatin modifying model suggests that barrier 
elements utilize chromatin modifying activities, which modify the underlying chromatin 
structure, making it less amenable for the spread of silenced chromatin. There are two variations 
of the chromatin modifying model. One variation suggests that silenced chromatin is restricted 
from spreading simply as a result of the competition between chromatin-opening and -
condensing factors at the boundary. Silencing is restricted from spreading by this mechanism at 
some native yeast telomeres (Kimura and Horikoshi 2004). The other variation suggests that the 
binding of sequence-specific factors (e.g. TFIIIC at the A and B box; TATA-like sequences for 
Pol III machinery components) to the barrier element creates a nucleosome-free region, and this 
nucleosome-free gap at the boundary is sufficient to block the spread of heterochromatic proteins 
(Bi, Yu et al. 2004).  
        The transcriptional potential of the tDNA barrier at HMR and the assembly of the RNA 
polymerase III transcription complex is shown to be critical for barrier function, as mutations in 
the tDNA promoter reduce barrier activity (Donze, Adams et al. 1999; Donze and Kamakaka 
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2001). Mutations in the genes for the RNA polymerase III transcription factors Brf1p or Tfc3p, 
or the HMR-tRNA gene itself prevents binding of these factors and thus weakens the boundary 
function (Donze and Kamakaka 2001). Nhp6a and Nhp6b, which have a demonstrated  role in 
Pol III transcription of the SNR6 (U6 RNA) gene and a subset of tDNAs, are also implicated in 
the barrier function of the HMR-tRNA as deletion of both genes substantially weakens the ability 
of the HMR-tRNA gene to block the propagation of Sir protein mediated silencing (Braglia, 
Dugas et al. 2007).  
        The deacetylase action of Sir2p has a preference for lysines 9 and 14 of H3 and K16 of H4 
in vitro (Imai, Armstrong et al. 2000; Tanny and Moazed 2001), whereas in vivo all acetylatable 
lysines of histones H3 and H4 are fully deacetylated at silenced loci (Suka, Suka et al. 2001). 
Enhanced silencing in an rpd3Δ background cannot be accounted for by increased expression of 
SIR genes since the only Sir protein required at all three silent loci in yeast, Sir2p, weakens 
silencing at the HM loci when SIR2 is overexpressed (Fritze, Verschueren et al. 1997; Smith, 
Brachmann et al. 1998). Overexpressing SIR4 also has the same effect of weakening silencing at 
all three silent loci (Sussel and Shore 1991; Renauld, Aparicio et al. 1993; Smith, Brachmann et 
al. 1998). The same situation would presumably apply to Sir1p. Unlike the initiation of silencing 
at the HM loci, SIR1 is not required for silencing at telomeres (Rine and Herskowitz 1987; 
Aparicio, Billington et al. 1991) and all but two telomeres, III-R and IV-L, are associated with 
silenced chromatin (Pryde and Louis 1999; Lieb, Liu et al. 2001).  
        The enhanced silencing effect at HMR in an rpd3Δ strain has mechanistically eluded 
researchers for nearly fifteen years, but recent research has implicated a redistribution of Sir 
proteins across the yeast genome based on global histone N-terminal modifications (Santos-
Rosa, Bannister et al. 2004; Venkatasubrahmanyam, Hwang et al. 2007; Zhou, Zhou et al. 2009). 
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In the early days of rpd3Δ silencing research, three separate hypotheses were proposed to explain 
the rpd3Δ effect on enhanced silencing (De Rubertis, Kadosh et al. 1996; Vannier, Balderes et al. 
1996; Rundlett, Carmen et al. 1998). The first was based on an indirect effect of increased 
expression of a critical, dosage-dependent silencing factor. This was highly unlikely because as 
mentioned earlier, it has been shown that increased SIR2 and/or SIR4 expression does not 
increase silencing at the HM loci but actually reduces it (Sussel and Shore 1991; Renauld, 
Aparicio et al. 1993; Fritze, Verschueren et al. 1997; Cockell, Gotta et al. 1998; Smith, 
Brachmann et al. 1998). The second hypothesis stated that the loss of Rpd3p function causes an 
increase in the acetylation of the H4 N-terminal lysine residue 12 which correlates with increased 
silencing, and because it was determined by ChIP to be specifically acetylated in the chromatin 
of the silent HM loci compared to the expressed MAT locus (Braunstein, Sobel et al. 1996). 
Recent evidence using a more specific antibody for the lysine 12 modification contradicts this 
notion of a hyperacetylation state correlating with silencing (Suka, Suka et al. 2001). The third 
hypothesis states that the activity of an unidentified silencing factor is modulated by acetylation 
on internal lysine residues. Loss of deacetylase activity would then hyperactivate the silencing 
factor leading to stronger silencing. 
        In its role as a histone deacetylase, Rpd3p does not necessarily participate in „global 
deacetylation‟ since the specificity is for histone proteins mainly at targeted gene promoters. The 
Rpd3 complex may bind directly and in a sequence-independent manner to histones or histone-
binding proteins for the subsequent „global deacetylation‟ of histones. Rpd3p is recruited to 
specific sites in the genome via interactions with multiple transcription factors, including Ume6p 
(Kadosh and Struhl 1997; Rundlett, Carmen et al. 1998) and the heterodimeric transcription 
factor Swi4/Swi6 (Robert, Pokholok et al. 2004). Initial studies on Rpd3p focused on its role in 
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the regulation of sporulation-specific genes through Ume6p, and then further studies revealed 
that Rpd3p regulates additional cellular functions. A set of genes occupied by Rpd3p encodes 
important cell cycle regulators including cyclins and cyclin-dependent kinases. This may 
explain, in part, the importance of Rpd3p in meiosis (Vannier, Balderes et al. 1996). Rpd3p and 
Sin3p occupy a total of approximately 100 genes (p<0.005) and, given that each is a component 
of the larger Rpd3(L) complex, are essentially associated with the same genes (Kurdistani, Robyr 
et al. 2002).  
        Through our genetic screen of UV-mutated rpd3Δ strains, we identified two genes, BRE1 
and BRE2, which are involved in the enhanced silencing effect of rpd3Δ at HMR and have a 
tremendous influence on global histone methylation. Our results also give the indication that 
regulation of both euchromatic and heterochromatic environments are more complex than 
previously thought. We are given clues as to the occurrence of possible indirect effects of both 
chromatin-binding and chromatin-influencing proteins on genomic environments along with the 
fact that the covalent modifications on the N-terminal tails of histone proteins are in a constant 
state of flux. The assayed cells only reflect a particular state at a particular moment in time of the 
underlying chromatin, but this constant state of flux can still allow certain histone modifications 
to serve as epigenetic marks for chromatin states.  
        The histone H3/H4 tetramer would be the likely candidate to serve as a location for 
epigenetic marks, since the passage of the replication fork causes the two H2A-H2B dimers to 
disassociate from both the H3-H4 tetramer and the DNA. The H3-H4 tetramers remain 
associated with DNA (Kimura and Cook 2001) and are randomly distributed to the sister 
molecules during replication (Jackson and Chalkley 1985). In the inheritance of the 
heterochromatic state (silenced regions), the H3-H4 tetramers disassociated from H2A-H2B 
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would be hypoacetylated and Sir proteins may remain associated with the H3 and H4 histone 
tails after the passage of the replication fork. Newly synthesized acetylated histones could be 
adjacent to old H3-and H4-bound Sir2p which would influence the deacetylation of the adjacent 
nucleosomes creating high affinity binding sites for Sir3p and Sir4p and thus the re-
establishment of silencing. The use of certain histone modifications as epigenetic marks is 
critical in S. cerevisiae, since there is no utilization of DNA modifications (i.e. CpG 
methylation). A new paradigm is beginning to emerge that the deacetylation of histones H3/H4 is 
not the only potential epigenetic mark to maintain silencing. This stands to be true as new 
evidence brings a higher complexity to histone modification states. Although core histones are 
among the most conserved proteins known in all organisms, they are also among the most 
diverse regarding posttranslational modifications.  
        Transcript levels of the two NAD
+
 biosynthesis genes detected in our genetic screen, QNS1 
and NPT1, were not significantly modulated between our WT and rpd3Δ strains. Studies have 
shown that only telomeric and rDNA silencing in S. cerevisiae are dependent on the nuclear 
NAD
+
 salvage pathway (Llorente and Dujon 2000) and mutations in the SIR2 gene itself does 
not significantly affect overall intracellular NAD
+
 concentration (Sandmeier, Celic et al. 2002). 
Another Sir2 family member of HDACs (class III NAD
+
-dependent), Hst2p, is actually 
responsible for most of the NAD
+
-dependent deacetylase activity from whole cell extracts 
(Smith, Brachmann et al. 2000). It is interesting to note that the NAD
+
-dependent glutamate 
dehydrogenase, GDH2, was identified in our genetic screen. Since GDH2 requires the cofactor 
NAD
+
 for its enzymatic activity of converting glutamate to α-ketoglutarate, it seems implausible 
that GDH2 would be an effector, since the requirements of Gdh2p would sequester the NAD
+
 
cofactor, thus inhibiting the availability of NAD
+
 to Sir2p and its effects on extended silencing at 
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HMR. Although GDH2 was not verified as a potential effector upon gene knockout, this scenario 
is still highly unlikely due to the numerous pathways for NAD
+
 to replenish in the cell. It may 
take changes in some or all of the NAD
+
 pathway genes to observe a significant change in NAD
+
 
concentration that would negatively affect Sir protein-mediated silencing at HMR. Topologically, 
it would be very efficient for the cell to replenish the nicotinamide by-product of the Sir2p 
deacetylase reaction back into NAD
+
 near the sites of silencing. This would ensure a constant 
supply of NAD
+
 for Sir2p in the nucleus.  
        Rad6p is involved in the ubiquitylation of histones H2A, H2B, and H3 in vitro (Sung, 
Prakash et al. 1988; Haas, Reback et al. 1990) which suggests a role for Rad6p as a modifier of 
localized chromatin structure (Picologlou, Brown et al. 1990; Kang, Yadao et al. 1992; Liebman 
and Newnam 1993). Early studies implicated Rad6-mediated ubiquitylation as a regulator of 
silencing in both S. cerevisiae and S. pombe (Bryk, Banerjee et al. 1997; Huang, Kahana et al. 
1997; Singh, Goel et al. 1998). Histone H2B is ubiquitylated by Rad6p at lysine residue 123 
through its association with the E3 ubiquitin ligase, Bre1p (Robzyk, Recht et al. 2000) which 
was an identified effector in our genetic screen. It has been previously shown that mutation of 
RAD6 or histone H2BK123 completely abolishes H3K4 methylation by Set1p, which illustrates 
the trans-histone dependence of this chromatin modification (Sun and Allis 2002). Rad6p is also 
involved in many cellular processes including DNA repair, UV-induced mutagenesis, N-end rule 
protein degradation, sporulation, and Ty1 integration specificity (Picologlou, Brown et al. 1990; 
Kang, Yadao et al. 1992; Liebman and Newnam 1993; Prakash, Sung et al. 1993). From our 
results, and because Rad6p is associated with BRE1, there could be a mechanistic association 
with rpd3Δ extended silencing. Could the mechanism be that silencing is dependent upon the 
ubiquitylation of a silencing regulator? One posed explanation is that Rpd3p regulates expression 
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of RAD6 which in turn is required for silencing, but it has been shown that Rad6p protein levels 
are unchanged between WT and rpd3Δ strains (Sun and Allis 2002). 
        The Bur1/Bur2 cyclin dependent protein kinase is required for histone H2B 
monoubiquitylation by Rad6/Bre1. Negative effects on histone monoubiquitylation and 
methylation can be the result of defective Bur1/Bur2-mediated phosphorylation of Rad6p on its 
serine residue 120 resulting in inhibited recruitment of the Paf1 complex, a Pol II elongation 
factor, to chromatin. Serine 120 of Rad6p has been shown to be required for silencing of 
telomere-associated genes, and the overall regulation of gene expression in vivo (Wood, 
Schneider et al. 2005). Mutation of Rad6p serine 120 to alanine leads to a loss of telomeric 
silencing comparable to that seen in mutants deleted for RAD6, BRE1, or RTF1, all of which are 
required for histone H2B monoubiquitylation and histone H3 methylation by COMPASS and 
Dot1p (Wood, Krogan et al. 2003).  
        COMPASS is a histone H3 lysine 4 (H3K4) methylase consisting of Set1p (KMT2) and 
seven other polypeptides, including Swd2p, the only essential subunit. H3K4 is methylated by 
the Set1p methyltransferase during transcriptional elongation, through association with the Ser5-
phosphorylated CTD of RNA polymerase II (Ng, Robert et al. 2003). The mechanism by which 
the Set1p methyltransferase of COMPASS differentially methylates H3 (mono-, di-, and tri-) is 
still not understood. Also, the molecular mechanisms for the histone crosstalk between histone 
H2B monoubiquitylation by Rad6/Bre1 and the H3K4 trimethylation by COMPASS are poorly 
understood. In the absence of H2B monoubiquitylation, H3K4 monomethylation is present, 
however, H3K4 di- and trimethylation are not detectable (Schneider, Wood et al. 2005; 
Shahbazian, Zhang et al. 2005). COMPASS purified from strains lacking H2B 
monoubiquitylation is incapable of di- and trimethylating histone H3K4 and has reduced levels 
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of the COMPASS subunit Swd2p.  Some findings offer insight into the molecular role of Swd2p 
in translating the H2B monoubiquitination signal into H3 methylation (Figure 4.1).   The Swd2p 
recruitment to chromatin via H2B monoubiquitination can bring this subunit in close proximity 
to COMPASS (interacting with Pol II through the Paf1 complex), resulting in their physical 
interactions, and therefore, H3K4 di- and trimethylation.     
 
Adapted from Lee et al. Cell, Vol. 131, 2007, p1092. 
 
 
 
 
      
         
Figure 4.1. Swd2p is required for translating histone crosstalk between H2B 
monoubiquitylation and H3 methylation by COMPASS. COMPASS interacts with the 
elongating form of Pol II via its interaction with Paf1 complex. A) In the absence of H2BK123 
monoubiquitylation by Rad6/Bre1, COMPASS can still interact with Pol II via the Paf1 complex 
and monomethylate H3K4. B) Through H2BK123 ubiquitylation, Swd2p is recruited to 
chromatin either directly or indirectly in a COMPASS independent manner. According to this 
model, the association of Swd2p with COMPASS can facilitate H3K4me3 through its 
association with another unspecified interaction between Swd2p and the monoubiquitylation of 
H2BK123. Through this mechanism dependent on ubiquitylation of H2BK123, Swd2p would 
also associate with Dot1p for the tri-methylation of H3K79.     
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        In a paf1Δ mutant, both H3K4me2 and H3K4me3 are eliminated, but H3K4me1 is not 
affected. Set1p can catalyze H3K4me1 independent of PAF1, thus independent of Pol II 
elongation, but conversion to H3K4me2 or -me3 requires PAF1 and association with Pol II. The 
association of Swd2p in a monoubiquitination-dependent manner can result in some 
posttranslational modification(s) of Swd2p which could facilitate the interaction of Swd2p with 
COMPASS (Lee, Shukla et al. 2007). 
        The proposed mechanism above is attractive since it explains how both BRE1 and BRE2 are 
participating in the methylation status of both H3K4 and H3K79. Particularly, it shows how 
BRE1 is required for the trimethylation of H3K4 and H3K79, but it also indicates how BRE2 is 
directly involved in the monomethylation of H3K4 and how there is a potentially allosteric 
involvement (through its association with COMPASS) in the enzymatic requirements of the 
trimethylation of H3K4; plus how this potential allosteric involvement through the association 
with Swd2p indirectly effects methylation of H3K79. Since both BRE1 and BRE2 are effectors 
of the rpd3Δ silencing effect identified in our results, it stands to reason that only the 
trimethylation status of H3K4 exerts its effects on Sir protein-mediated silencing, but the 
influence of H3K79 methylation may be far more reaching than previously thought. The question 
that remains is how the trimethylation of H3K4 and/or H3K79 is involved in the extended 
silencing effect of rpd3Δ at HMR.  
        An interesting and plausible hypothesis for BRE1‟s influence on rpd3Δ enhanced silencing 
comes through the interaction of NAT1-acetylated Sir3p with methylated H3K79. It has been 
shown that the binding of Sir3p to histone peptides in vitro is negatively affected by the 
methylation and acetylation of the tails of histone H3 and H4 (Carmen, Milne et al. 2002; 
Santos-Rosa, Bannister et al. 2004; Liou, Tanny et al. 2005). Binding of Sir3p to histone tails 
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throughout the genome is mediated by the C-terminus of Sir3p (Gasser and Cockell 2001). The 
C-terminus of Sir3p contains a BAH domain that binds to histone H3K79. Importantly, 
acetylation of the BAH domain is required for the binding specificity of Sir3p for nucleosomes 
unmethylated at H3K79 (van Welsem, Frederiks et al. 2008) (Figure 4.2).  
 
Adapted from van Welsem et al. Mol. Cell Bio, Vol. 28 No.11, 2008, p.3869. 
 
 
 
 
         
 
        With the deletion of Dot1p, binding of Sir2p and Sir3p at silent chromatin is reduced, and 
Sir3p becomes redistributed (San-Segundo and Roeder 2000; Ng, Feng et al. 2002; van 
Leeuwen, Gafken et al. 2002; Ng, Robert et al. 2003) which can reduce silencing at HMR. This 
same scenario can apply to the deletion of BRE1 since Dot1p trimethylation at H3K79 is 
Figure 4.2. Model for the interaction between Dot1p and the acetylated N-terminus of Sir3p 
in silencing. Sir1 recruits the Sir 2/3/4 complex in cis to the E silencer at HMRa. Dot1p acts by 
methylation (me) of histone H3K79 in euchromatic regions which prevents promiscuous binding 
of Sir proteins, thus concentrating the Sir proteins at HMRa in trans. The N-terminus of the BAH 
domain of Sir3p interacts with the core domain of the nucleosome encompassing H3K79, 
whereby the acetylated Sir3p is able to discriminate between methylated and unmethylated 
H3K79 and preferably binds to unmethylated H3K79. In the absence of acetylated Sir3p, Sir3p 
loses its specificity for unmethylated H3K79 and binds to euchromatic regions thus diluting Sir 
protein concentration at HMRa.  
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dependent on the ubiquitylation of H2BK123 mediated by Rad6/Bre1 (Figure 4.1). Some genetic 
evidence is consistent with this model in which the N-terminus of the BAH domain of Sir3p 
binds histone H3K79 on the nucleosome core. Specific point mutations in the Sir3p N-terminus, 
the deletion of NAT1 (N-terminal acetyltransferase), and the deletion of DOT1 each had very 
similar silencing phenotypes that showed reduced telomeric silencing (van Welsem, Frederiks et 
al. 2008). It would be interesting to see if a decrease in extended silencing occurs at HMR upon 
deletion of NAT1 in the rpd3Δ background.  
        Based on results by van Welsem et al. (2008), the Sir3p N-terminus binds the nucleosome 
core on a surface that includes histone H3K79 and acetylation of the Sir3 N-terminal alanine is 
required for the specificity of Sir3p for unmethylated histone H3K79. In the absence of this 
specificity (mutant or unacetylated Sir3p or no histone H3K79me in euchromatin), Sir3p 
becomes a promiscuous chromatin-binding factor, which leads to reduced Sir3p binding in silent 
regions, since Sir3p is in limited supply (van Welsem, Frederiks et al. 2008) (Figure 4.2). 
Biochemical studies (Onishi, Liou et al. 2007) demonstrate the binding of the Sir3p BAH domain 
to yeast nucleosomes is negatively affected by H3K79me, although it is not clear whether these 
interactions also occur with nucleosomes in vivo (van Welsem, Frederiks et al. 2008). 
        Sir2p has been shown to be mainly localized to two distinct sub-nuclear domains, telomeres 
and the nucleolus (Gotta, Strahl-Bolsinger et al. 1997). The nucleolus has been proposed to serve 
as a reservoir for Sir2p storage, competing with subtelomeric regions and HM loci for a limiting 
supply of Sir2p (Maillet, Boscheron et al. 1996; Gotta, Strahl-Bolsinger et al. 1997; Smith, 
Brachmann et al. 1998). A global redistribution of a limited pool of Sir2–4 to euchromatin would 
be expected to result in weak silencing at euchromatic loci, thus the depletion of Sir proteins 
from heterochromatic regions resulting in dramatically reduced silencing. The fact that Sir3p is 
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undetectable at euchromatic loci by ChIP suggests that, compared with Sir protein association at 
sites near and within the silenced loci, ectopic Sir binding is much weaker and/or transient and 
occurs at a given gene only in a fraction of all cells (Venkatasubrahmanyam, Hwang et al. 2007).  
        In accordance with the view that Sir proteins can be redistributed in the nucleus, 
immunolocalization studies of Sir2p showed that in H4K5Q rpd3Δ cells, most of the Sir2p signal 
was congregated in the nucleolus instead of diffused throughout the nucleus as was observed in 
rpd3Δ cells with wild-type histone proteins. These observations indicate that deacetylation of 
H4K5 by Rpd3p is likely required for restricting the spread of Sir2p into euchromatic regions 
and is important for limiting heterochromatic silencing. Considering that H4K5 is one of the 
targets of Rpd3p, it has been postulated that boundary formation in the subtelomeric and HMR 
regions requires H4K5 deacetylation (Zhou, Zhou et al. 2009); again however, it is 
counterintuitive to rationalize how an increase in H4 acetylation would be important for the 
propagation of heterochromatin. When Rpd3p is absent, could an increase of H4K5 acetylation 
facilitate Sir2p binding? The mechanism as to how the increase of H4 acetylation caused by 
Rpd3p inactivation facilitates the establishment of silent chromatin remains mysterious, and 
requires further investigation.  
        The deacetylation reaction of Sir2p is distinct from that of non NAD
+
-dependent HDACs in 
that it not only produces nicotinamide as a by-product, but also an unusual compound, O-acetyl-
ADP ribose (OAADPR) (Tanner, Landry et al. 2000), which has been proposed to influence SIR 
complex stability (Liou, Tanny et al. 2005). Another proposed mechanism based on recent 
evidence suggests histone deacetylation by Rpd3p removes the substrate for Sir2p (H4K16), so 
that Sir2p no longer can produce O-acetyl-ADP ribose (OAADPR) by consumption of NAD
+
 in 
the deacetylation reaction. In this model, OAADPR therefore is unavailable for binding to Sir3p, 
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preventing SIR complex propagation (Ehrentraut, Weber et al. 2010). Intriguingly, the Sir3 
protein carries a domain that resembles the ATP binding pocket of AAA+ ATPases but lacks 
certain catalytic residues (Neuwald, Aravind et al. 1999). It therefore has been hypothesized that 
this domain constitutes an OAADPR binding site (Gasser and Cockell 2001). Therefore, 
heterochromatin spreading is stopped by the inability of Sir2p to perform histone deacetylation, 
to produce OAADPR, and thus to support heterochromatin spreading.    
        In light of recent evidence, the loss of silencing at HMR that was observed in our double 
mutants, bre1Δrpd3Δ and bre2Δrpd3Δ, could be the result of the loss of H3K4me3 and 
H3K79me3 genome-wide, which would promote the promiscuous binding of Sir proteins into 
euchromatic regions, thus diluting them from areas of typical heterochromatic dominance.       
 
 
 
 
Figure 4.3. Model of the re-distribution of Sir proteins in wild-type vs. rpd3Δ cells. Normal 
silencing at HMR occurs due to adequate concentration of Sir proteins at this region with limited 
promiscuous binding of Sir proteins in euchromatic regions in wild-type cells. The loss of the 
deacetylase Rpd3p results in a loss of global deacetylation and fewer deacetylated histone targets 
in euchromatic regions. The limited pool of Sir proteins would concentrate higher at the normal 
silenced region of HMR resulting in an increase of extended silencing enough to bypass the tRNA 
barrier and silence the downstream ADE2 gene 
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How does this relate to the global loss of deacetylation in an rpd3Δ strain? Since our study 
mainly focuses on elucidating the mechanism of extended silencing at HMR, we posit a model 
where in wild-type cells, the limiting pool of Sir proteins are concentrated enough at HMR to 
repress the transcription of the a-specific mating type genes, but not concentrated enough to 
bypass the tRNA barrier element and silence the downstream ADE2 gene (Figure 4.3).  
        In this model, a fraction of the silencing proteins are distributed to other chromosomal 
regions near euchromatic regions where deacetylated nucleosomes are always potential targets of 
transient or limited binding of Sir proteins. In rpd3Δ strains, the global loss of deacetylation 
causes a subsequent increase in the global acetylation of nucleosomes, which would inhibit the 
binding of Sir proteins to euchromatic regions. The distribution of this freed pool of Sir proteins 
would shift to heterochromatic regions such as HMR, which could override the tRNA barrier 
element and silence the ADE2 marker gene. So, is the increasing silencing effect of rpd3Δ due to 
a global re-distribution of Sir proteins based on the acetylation status of euchromatic regions? 
        DamID (DNA adenine methyltransferase) methodology, first established in Drosophila 
melanogaster, is a method used to profile chromatin-associated proteins (van Steensel and 
Henikoff 2000). Studies using the fusion of Sir3p and Sir4p to Escherichia coli Dam in wild-type 
and set1Δhtz1Δ strains resulted in Dam-mediated DNA methylation at sites where Sir3p or Sir4p 
was bound to chromatin. With no endogenous DNA methylation in S. cerevisiae, the percentage 
of cells methylated at a particular locus provided a read-out of the chromatin association of Sir3p 
or Sir4p (Venkatasubrahmanyam, Hwang et al. 2007). Sir-dam fusion proteins result in 
methylated GATC sites at Sir protein bound sites in the genome, and can be digested by the 
restriction endonuclease DpnI. Oligo primer sets targeted at specific genomic locations can 
reveal the presence or absence of site-specific methylation depending on whether that region has 
116 
 
been cut by DpnI (no amplification) or not (amplification). Thus, regions in the genome that 
have been occupied by either Sir3p or Sir4p can be assessed by reduced amplification using 
PCR. 
 
 
 
 
 
 
Currently, our experimentation involves creating both Sir3p and Sir4p functional proteins fused 
to an E. coli dam methylase (Figure 4.4). Dam methylase of E. coli catalyzes the transfer of a 
methyl group from S-adenosyl-methionine (AdoMet) to the N6 amino group of the adenine in 
the sequence GATC (Hattman, Brooks et al. 1978; Geier and Modrich 1979). Our initial 
restriction assays using unfused wild-type dam methylase (Sir4pr-dam) showed high global 
DNA methylation across the entire genome. This high background made it difficult to distinguish 
targeted from untargeted Dam methylation. To attempt to refine the assay, we reasoned that 
creating catalytic mutants in the Dam methylase might improve the signal-to-noise ratio at Sir 
targeted sites. Based on previous studies of Dam methylase activity, we created three mutations, 
Figure 4.4. Strategy for the genome-wide assessment of Sir proteins using Sir3- or Sir4-dam 
methylase fusion proteins. By utilizing Sir3p or Sir4p fused to the E. coli dam methylase, which 
contains functionally reduced methylase activity due to conditional mutations in the DNA 
binding domain of the enzyme, we can assess the degree of transient Sir protein occupancy in 
euchromatic regions and in higher affinity binding heterochromatic regions by the degree of 
DNA methylated at GATC sequences. Methylation-specific restriction endonucleases along with 
oligo primer sets probing targeted genomic loci can assess limited Sir protein binding. 
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P134S which contains a specific methylase activity of 66% of wild type Dam, G136A (42%), 
and R137L (6%) (Guyot, Grassi et al. 1993). Future studies will use unfused dam methylase 
mutants driven by the Sir4 promoter region for normalization of this assay. The inherent 
extended silencing effect of rpd3Δ at HMR shows that barrier elements such as the tRNAthr gene 
can be overcome by Sir protein-mediated silencing when various chromatin processes are 
perturbed. As each new piece of evidence contributes to the puzzle, we are progressively getting 
a better understanding of the true complexity of barriers in the context of an extremely dynamic 
genome.  
        Like previous studies in our lab, our latest study (autoregulation of TFC6 by TFIIIC in the 
TFC6 promoter) is solidifying the role of TFIIIC binding sites as genomic elements with extra-
transcriptional functions. Our results implicate the B box sequence element of type II RNA 
polymerase III (tRNA) genes and ETC sites in insulator function. The question remains if other 
ETC sites in budding yeast to humans carry the same regulatory capacity in blocking targeted 
activation between genomic domains. It is interesting to speculate how these B box elements 
might have been evolutionarily selected to function in an insulator capacity.  
        The yeast genome contains 274 unclustered tRNA genes which are dispersed throughout its 
genome of 16 chromosomes (32 in diploid strains) (Percudani, Pavesi et al. 1997; Hani and 
Feldmann 1998). tDNAs are represented as gene sets which redundantly code for 42 tRNA 
species with different codon specificities. Individual tRNA species range in copy number from 1 
to 16 and correlates with both the frequency of codon occurrence on mRNAs and the 
intracellular amount of individual tRNAs (Percudani, Pavesi et al. 1997). Because of tDNA 
redundancy, and the intragenic location of the A and B blocks, genes coding for the same tRNA 
species in eukaryotes generally share identical TFIIIC-binding promoter elements, but are flanked 
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by divergent TFIIIB interacting sequences (Hani and Feldmann 1998). Can varying the nuclear 
concentration of TFIIIC differentially control the transcriptional outputs of the various tRNA 
gene families? Our results have indicated that overexpression of the TFIIIC component TFC6 
increases relative TFIIIC binding at representative tDNA and ETC loci (Figure 3.10). With excess 
TFIIIC present, transcriptional output would be proportional to the tRNA gene copy number, but 
with limiting TFIIIC the output would be determined by TFIIIC binding affinity to these loci. It is 
intriguing to speculate that the cell might exploit varying TFIIIC binding constants based on 
Tfc6p levels in the cell to differentially regulate the transcriptional outputs of its various tRNA 
gene families.  
        The origin of isolated B box sequences dispersed throughout the yeast genome, which are 
overrepresented between divergently transcribed Pol II genes, remains an interesting 
evolutionary notion about the multi-functionality of tRNA genes that are progressively being 
discovered. Are ETC loci remnants of early tRNA genes, but have lost A box sequences and 
functional TATA-like sequences just upstream of the RNA initiation site since these upstream 
sequences heavily influence Pol III transcription in vivo and in vitro by facilitating the 
association of TFIIIB? However, many Pol III promoters lack canonical TATA elements and the 
transcriptional effects of the TATA-like sequences are quantitatively modest. Do the ETC loci 
have DNA sequences that result in positioned nucleosomes that do not interfere with TFIIIC 
binding, but essentially block the association of TFIIIB and Pol III? Are DNA-binding proteins 
bound at critical positions at the ETC loci blocking the association or recruitment of TFIIIB and 
Pol III while not affecting association of TFIIIC? Is TFIIIC bound at the ETC loci in a 
conformation that precludes its association with TFIIIB? 
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        From an evolutionary perspective, the ETC loci may be false Pol III promoters that were 
derived from vestigial Pol III genes or could be just fortuitous occurrences of TFIIIC recognition 
sequences. The highly conserved promoter sequences between species surely make the former 
highly probable. Expanding on this idea, especially in light of the sequence conservation among 
related yeast species is that some (and perhaps all) ETC loci are bona-fide Pol III promoters at 
which the complete Pol III apparatus assembles only under specific conditions. Perhaps a 
modification of TFIIIC or TFIIIB in response to a specific environmental or genetic condition 
might permit the recruitment of the intact Pol III machinery to the ETC loci. Alternatively, a 
given condition might result in the dissociation of an inhibitory factor that blocks TFIIIB and Pol 
III entry at these loci; this could possibly have implications for other mechanisms of regulation 
of the neighboring genes. It can be difficult to distinguish between true functional elements and 
evolutionary remnants, though the potential to identify new classes of functional elements 
always exists. For example, TFIIIC binding sites have the capacity to function as an insulator, as 
either a tDNA or an ETC sequence can block the interaction of Gal4p with the GAL10 promoter. 
TRT2 tDNA in its natural context serves as an insulator between the STE6 and CBT1 genes, 
preventing the STE6 regulatory elements from affecting CBT1 transcription levels (Simms, 
Miller et al. 2004). 
        RNA170 (ETC5) was found as a new, non-essential 170 nucleotide non-coding RNA 
transcript (Olivas, Muhlrad et al. 1997; Roberts, Stewart et al. 2003). Following genome-wide 
ChIP-CHIP of subunits of Pol III, TFIIIB, and TFIIIC, the low levels of Pol III and TFIIIB that 
were present at this locus suggested that RNA170 may be transcribed at very low levels (Roberts, 
Stewart et al. 2003). ZOD1 (Zone Of Disparity), which possibly produces short transcripts, is so 
named because occupancy by Pol III was initially found to be disproportionately low when 
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compared with TFIIIC occupancy (Moqtaderi and Struhl 2004). Nucleosome depletion 
dramatically enhances expression of both ZOD1 and ETC5 without affecting their occupancy by 
the Pol III machinery (Guffanti, Percudani et al. 2006). The ZOD1 locus is also bound by all 
components of the Pol III machinery and was initially implicated as a promoter that is bound by 
a transcriptionally incompetent form of the complete Pol III machinery (Stunkel, Kober et al. 
1997; Moqtaderi and Struhl 2004). The ZOD1 region is riddled with poly(dT) stretches, which 
can act as termination signals for Pol III, so the resulting short RNAs are likely to be quickly 
degraded and hence difficult to detect. Although this model might imply that ZOD1 is a 
meaningless pseudogene or other genomic relic, the high conservation in yeast of the ZOD1 A 
and B blocks, as well as the conserved binding of Pol III factors to this locus suggest that any 
localized Pol III transcription may have a physiological function. Comparative genomic analysis 
revealed that the ZOD1 promoter is the only surviving portion of a tDNA
Ile
 ancestor, whose 
transcription capacity has been preserved throughout evolution independently from the encoded 
RNA product. Another TFIIIC/TFIIIB-associated element in the S. cerevisiae genome, iYGR033c, 
was also identified as a conserved tDNA
Arg
 remnant (Guffanti, Percudani et al. 2006). 
        In S. pombe, inverted repeat (IR) boundary elements flanking the mating-type 
heterochromatin domain also contain B-box sequences, which prevent heterochromatin from 
spreading into neighboring euchromatic regions by recruiting the TFIIIC complex without Pol III. 
The IR elements actually contain multiple B box sequences that are also required for efficient 
transcription of IRs by RNA Pol II. This finding resulted in a subsequent genome-wide profiling 
analysis which unexpectedly identified a number of COC sites dispersed across the fission yeast 
genome. These TFIIIC-bound sequences are tethered to the nuclear periphery in a B box 
dependent manner (Noma, Cam et al. 2006). Similar to the IR boundaries, multiple B boxes are 
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located at these TFIIIC bound regions. Interestingly, most of these loci were found in intergenic 
regions between divergent Pol II genes and one of the divergent Pol II promoter regions 
occupied by TFIIIC is the gene SFC3 (TFC6 ortholog in Saccharomyces), suggesting the 
potential for transcriptional autoregulation of SFC3 by TFIIIC in fission yeast (Noma, Cam et al. 
2006). ETC loci in budding yeast might have a role in genome organization via the tethering of 
specific chromosomal regions to subnuclear structures, akin to the clustering of tRNA genes near 
the nucleolus (Thompson, Haeusler et al. 2003).  
        Recent ChIP, followed by massive parallel sequencing (ChIP-Seq), data of Pol III 
components puts the human ETC site list at 5,474 loci, in contrast with 1,520 for the RNA Pol III 
subunit Rpc155, even though fold enrichments, and hence assay sensitivity, is higher for 
Rpc155. In these studies, an ETC locus was defined as having a TFIIIC/Rpc155 ratio higher than 
2.04, 3 s.d. above this median ratio. ETCs by this definition do not need to be completely lacking 
in Pol III occupancy. Under these strict experimental criteria (only 3 tRNAs passed), 1,865 ETCs 
were identified and the distribution of TFIIIC-occupied loci of both ETC and some non-ETC 
types revealed a positional bias toward the transcription start sites (TSSs) of Pol II genes. 181 
ETC loci with the highest levels of TFIIIC occupancy were strikingly well correlated with the 
TSSs of Pol II genes, with 68% being located within 1 kilobase of a Pol II TSS (Moqtaderi, 
Wang et al. 2010). This is reminiscent of the S. cerevisiae ETCs, which are ~200–300 bp 
upstream of a neighboring Pol II gene. Interestingly, these studies also revealed differences in 
TFIIIC occupancy at ETC loci between HeLa S3 and K562 cells suggesting that TFIIIC binding 
and/or TFIIIB recruitment at ETC loci is possibly influenced by cell type specific factors 
(Moqtaderi, Wang et al. 2010). While the genomic role of ETC sites has not been studied in 
depth, our results suggest that TFIIIC binding sites may have general functions as boundary 
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elements, and in the specific example of the TFC6 promoter, may function as an autoregulated 
insulator (Figure 4.5). 
 
 
 
 
 
        Relative levels of the Tfc6 protein are lower as compared to other essential TFIIIC subunits 
(Ghaemmaghami, Huh et al. 2003; Kleinschmidt, Leblanc et al. 2011), so the auto-regulatory 
mechanism at the TFC6 promoter gives credence to Tfc6p as a limited component to TFIIIC 
assembly/binding, thus having a potentially tremendous impact on maintaining cellular TFIIIC 
levels. Does this affect the overall regulation of tRNA genes? Since our results indicate that the 
regulation of TFC6 is dose-dependent on the levels of its own protein product, we also 
investigated the global effect of TFC6 overexpression on other Pol III promoter elements such as 
tRNA genes and other ETC loci in the yeast genome. Currently, there are no other studies 
showing that overexpression of any TFIIIC component causes an increase in either TFIIIC binding 
to tRNA genes or ETC sites. Future overexpression studies of TFC6 will mainly focus on the 
effects at tRNA genes and the possible effects of regulatory output. ChIP-Seq analysis should 
Figure 4.5. TFIIIC potentially functions as an insulator to the targeted activation of the 
TFC6 promoter by a putative DNA-binding transcription factor. The binding of the TFIIIC 
complex to the ETC6 site is autoregulated by its own protein product and inhibits the targeted 
activation and the assembly of a preinitiation complex either through steric hindrance or the 
blockage of a tracking mechanism at the TFC6 promoter resulting in lower TFC6 expression. 
Directional TF targeting near the TSS of TFC6 has been omitted for clarity. 
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give us whole-genome data determining which TFIIIC-occupied loci shows higher enrichment 
upon overexpression of TFC6. Also, it is technically difficult to measure the transcriptional 
activity of individual tRNA genes because most are repeated. Based on ChIP-Seq data, we can 
assay any Pol III transcribed gene of interest by tagging the tRNA genes showing higher TFIIIC 
binding upon TFC6 overexpression. 
        The lower levels of TFC6 expression in our promoter mutant #3 also points to a potential 
DNA-binding protein that seems to function as a transcriptional activator for TFC6, which could 
participate in the assembly of an RNA Pol II initiation complex near the TSS of TFC6. Sequence 
analysis of this promoter region shows sequence similarity to the DNA-binding site of Reb1p. 
The role of Reb1p, as the putative DNA-binding transcription factor, is currently being assessed 
by analyzing the effects of REB1 overexpression on TFC6 promoter activity. If Reb1p is the 
putative transcription factor bound to promoter region #3, then overexpressing REB1 should 
ultimately show increased rate of growth on media lacking uracil in our TFC6 promoter-URA3 
strains described in Chapter 3.         
        Reb1p is among the abundant so-called “general regulatory factors.” It is a multifunctional 
transcription factor encoded by an essential gene. The 125-kDa protein binds as a monomer to its 
site on DNA with the consensus YNNYYACCCG, and its DNA-binding domain is homologous 
to the vertebrate proto-oncogene myb. Reb1p has an architectural role, and its DNA binding is 
necessary and sufficient to keep nucleosomes off the DNA region spanning the core promoter 
(Ju, Morrow et al. 1990; Morrow, Ju et al. 1993).  
        An alternative hypothesis to the role of TFIIIC as an insulator can include another proposed 
mechanism of regulation at the TFC6 promoter region. There is the possibility of competitive 
binding between the unknown DNA-binding protein and TFIIIC at the short stretch of DNA 
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between promoter region #3 and the ETC6 site (Figure 4.6). Since the TFC6 promoter element 
(promoter region #3) is immediately upstream of the ETC6 B-box (~12bp), it stands to reason 
that TFIIIC when bound might occlude the binding of the transcription factor resulting in 
decreased TFC6 expression (Figure 4.6 B). The same situation could occur with the transcription 
factor bound at promoter region #3 where the assembly of the entire TFIIIC complex is inhibited 
resulting in increased TFC6 expression (Figure 4.6 A). 
 
 
 
         
 
        It is clearly evident that chromatin boundary elements play an expanding role in the natural 
context of eukaryotic genomes. The extra-transcriptional effects of tDNAs (tRNA genes) and the 
influence they have on gene regulation and chromatin organization show that eukaryotic 
Figure 4.6. Competition between TFIIIC and transcription factor (TF) for binding the 
limited region of putative UAS and ETC6. A) In the competition model of TFC6 transcription 
activation, the binding of the putative transcription factor to promoter region #3 occludes the 
binding of TFIIIC to the ETC6 site and activates TFC6 transcription. B) Increased levels of 
TFIIIC will bind to the ETC6 site and occlude the putative transcription factor from binding at 
the promoter region #3 thus lowering TFC6 expression.    
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genomes are not only dependent on the sequence of nucleotides on chromosomes, but are also 
epigenetically controlled at all stages of cellular differentiation in the life of all eukaryotic 
organisms.  
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